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Abstract 
Acid-sensing ion channels (ASICs) are non-voltage-gated sodium channels activated by an extracellular acidification. They 
are widely expressed in neurons of the central and peripheral nervous system. ASICs have a role in learning, the expression 
of fear, in neuronal death after cerebral ischemia, and in pain sensation. Tissue damage leads to the release of inflammatory 
mediators. There is a subpopulation of sensory neurons which are able to release the neuropeptides calcitonin gene-related 
peptide (CGRP) and substance P (SP). Neurogenic inflammation refers to the process whereby peripheral release of the 
neuropeptides CGRP and SP induces vasodilation and extravasation of plasma proteins, respectively. Our laboratory has 
previously shown that calcium-permeable homomeric ASIC1a channels are present in a majority of CGRP- or SP-expressing 
small diameter sensory neurons.  
In the first part of my thesis, we tested the hypothesis that a local acidification can produce an ASIC-mediated calcium-
dependant neuropeptide secretion. We have first verified the co-expression of ASICs and CGRP/SP using immunochemistry 
and in-situ hybridization on dissociated rat dorsal root ganglion (DRG) neurons. We found that most CGRP/SP-positive 
neurons also expressed ASIC1a and ASIC3 subunits. Calcium imaging experiments with Fura-2 dye showed that an 
extracellular acidification can induce an increase of intracellular Ca2+ concentration, which is essential for secretion. This 
increase of intracellular Ca2+ concentration is, at least in some cells, ASIC-dependent, as it can be prevented by amiloride, an 
ASIC antagonist, and by Psalmotoxin (PcTx1), a specific ASIC1a antagonist. We identified a sub-population of neurons 
whose acid-induced Ca2+ entry was completely abolished by amiloride, an amiloride-resistant population which does not 
express ASICs, but rather another acid-sensing channel, possibly transient receptor potential vanilloïde 1 (TRPV1), and a 
population expressing both H+-gated channel types. Voltage-gated calcium channels (Cavs) may also mediate Ca
2+ entry. Co-
application of the Cavs inhibitors (ω-conotoxin MVIIC, Mibefradil and Nifedipine) reduced the Ca
2+ increase in neurons 
expressing ASICs during an acidification to pH 6. This indicates that ASICs can depolarise the neuron and activate Cavs. 
Homomeric ASIC1a are Ca2+-permeable and allow a direct entry of Ca2+ into the cell; other ASICs mediate an indirect entry 
of Ca2+ by inducing a membrane depolarisation that activates Cavs. We showed with a secretion assay that CGRP secretion 
can be induced by extracellular acidification in cultured rat DRG neurons. Amiloride and PcTx1 were not able to inhibit the 
secretion at acidic pH, but BCTC, a TRPV1 inhibitor was able to decrease the secretion induced by an extracellular 
acidification in our in vitro secretion assay. 
In conclusion, these results show that in DRG neurons a mild extracellular acidification can induce a calcium-dependent 
neuropeptide secretion. Even if our data show that ASICs can mediate an increase of intracellular Ca2+ concentration, this 
appears not to be sufficient to trigger neuropeptide secretion. TRPV1, a calcium channel whose activation induces a sustained 
current – in contrary of ASICs – played in our experimental conditions a predominant role in neurosecretion. 
In the second part of my thesis, we focused on the role of ASICs in neuropathic pain. We used the spared nerve injury (SNI) 
model which consists in a nerve injury that induces symptoms of neuropathic pain such as mechanical allodynia. We have 
previously shown that the SNI model modifies ASIC currents in dissociated rat DRG neurons. We hypothesized that ASICs 
could play a role in the development of mechanical allodynia. The SNI model was performed on ASIC1a, -2, and -3 knock-
out mice and wild type littermates. We measured mechanical allodynia on these mice with calibrated von Frey filaments. 
There were no differences between the wild-type and the ASIC1, or ASIC2 knockout mice. ASIC3 null mice were less 
sensitive than wild type mice at 21 day after SNI, indicating a role for ASIC3. Finally, to investigate other possible roles of 
ASICs in the perception of the environment, we measured the baseline heat responses. We used two different models; the tail 
flick model and the hot plate model. ASIC1a null mice showed increased thermal allodynia behaviour in the hot plate test at 
three different temperatures (49, 52, 55°C) compared to their wild type littermates. On the contrary, ASIC2 null mice showed 
reduced thermal allodynia behaviour in the hot plate test compared to their wild type littermates at the three same 
temperatures. 
We conclude that ASIC1a and ASIC2 in mice can play a role in temperature sensing. It is currently not understood  how 
ASICs are involved in temperature sensing and what the reason for the opposed effects in the two knockout models is. 
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Résumé 
Les canaux sensibles aux protons (ASICs) sont des canaux sodiques non voltages dépendants activés par une acidification 
extracellulaire. Ils sont largement exprimés dans les neurones du système nerveux central et périphérique. Les ASICs ont un 
rôle dans l’apprentissage, l’expression de la peur, dans la mort neuronale après une ischémie cérébrale, ainsi que dans la 
sensation de douleur. Un dommage tissulaire conduit au relâchement de médiateurs inflammatoires. Il y a une sous-
population de neurones sensoriels qui sont capables de relâcher les neuropeptides calcitonin gene-related peptide (CGRP) et 
substance P (SP). L’inflammation neurogénique réfère au processus lorsque le relâchement périphérique de neuropeptides 
CGRP et SP induit respectivement  la vasodilatation et l’extravasation de plasma. Notre laboratoire a montré précédemment 
que les canaux homomériques ASIC1a sont présents dans la majorité des neurones de petits diamètres exprimant le CGRP et 
la SP. 
Dans la première partie de ma thèse, nous avons testé l’hypothèse selon laquelle une acidification locale peut produire une 
sécrétion de peptide médiée par les ASICs. Nous avons tout d’abord vérifié la co-expression des ASICs et de CGRP/SP en 
utilisant l’immunocytochimie et l’hybridation in-situ sur des neurones dissociés de ganglions de racine dorsale (DRG). Nous 
avons trouvé que la plupart des neurones positifs pour CGRP/SP exprimaient aussi les sous-unités ASIC1a et ASIC3. Des 
expériences d’imagerie calcique avec le colorant Fura-2 ont montré qu’une acidification extracellulaire peut induire une 
augmentation de Ca2+ intracellulaire, qui est essentielle pour la sécrétion. Cette augmentation de concentration de Ca2+ 
intracellulaire est, au moins dans certaines cellules, dépendant d’ASIC, car elle peut être empêchée par l’amiloride, un 
antagoniste d’ASIC et par la Psalmotoxine (PcTx1), un antagoniste spécifique d’ASIC1a. Nous avons identifié une sous-
population de neurones dans laquelle l’entrée de Ca2+ a été complètement abolie par l’amiloride, une population résistante à 
l’amiloride qui n’exprime pas d’ASICs, mais plutôt un autre canal sensible aux protons, possiblement TRPV1, et une 
population exprimant les deux types de canaux sensibles aux protons. Les canaux calciques voltage dépendants (Cavs) 
peuvent aussi médier l’entrée de calcium. La co-application des inhibiteurs de Cavs (ω-conotoxin MVIIC, Mibefradil et 
Nifedipine) a réduit l’augmentation de Ca2+ dans des neurones exprimant des ASICs lors d’une acidification à pH 6. Cela 
indique que les ASICs peuvent dépolariser les neurones et activer les Cavs. Les ASIC1a homomériques sont perméables au 
calcium et permettent une entrée directe de calcium dans la cellule; les autres ASICs médient une entrée indirecte de Ca2+ en 
induisant une dépolarisation de la membrane qui active les Cavs.  Nous avons montré avec un essai de sécrétion que la 
sécrétion de CGRP peut être induite par une acidification extracellulaire des neurones de DRG de rats. L’Amiloride et la 
PcTx1n’ont pas pu inhiber la sécrétion à pH acide, mais le BCTC, un inhibiteur de TRPV1a été capable de diminuer, dans 
notre essai de sécrétion in vitro, la sécrétion lors d’une acidification extracellulaire. 
Pour conclure, ces résultats montrent que dans les neurones de DRG, une légère acidification peut induire une sécrétion de 
neuropeptides dépendante Ca2+. Même si nos données montrent que les canaux ASICs peuvent médier une augmentation de 
la concentration de Ca2+ intracellulaire, cela n’apparait pas comme suffisant pour activer la sécrétion de neuropeptides. 
TRPV1, un canal calcique dont l’activation induit un courant soutenu – au contraire des ASICs – a joué, avec nos conditions 
expérimentales, un rôle prédominant dans la sécrétion. 
Dans une deuxième partie de ma thèse, nous nous somme concentré sur le rôle des ASICs dans la douleur neuropathique. 
Nous avons utilisé le modèle SNI qui consiste en une blessure du nerf qui induit des symptômes de douleurs neuropathiques 
comme une allodynie mécanique. Nous avions précédemment montré que le modèle SNI modifie les courants ASICs  dans 
des neurones de DRG de rat dissociés. Nous avons émis l’hypothèse que les ASICs pourraient jouer un rôle dans le 
développement de l’allodynie mécanique. Le modèle SNI a été effectué sur  des souris knockout pour ASIC1a, -2, et -3 et des 
souris de type sauvage. Nous avons mesuré l’allodynie mécanique sur ces souris avec des filaments von Frey calibrés. Il n’y 
avait pas de différence entre les souris sauvages et les souris ASIC1a et ASIC2 knockout. Les souris ASIC3 knockout étaient 
moins sensibles que les souris sauvages 21 jours après le SNI, indiquant un rôle des ASIC3. Finalement, pour investiguer 
d’autres rôles possibles des ASICs dans la perception de l’environnement, nous avons mesuré les réponses de base à la 
chaleur. Nous avons utilisé deux différents modèles; le modèle de « tail flick » et de la « plaque chaude ». Les souris ASIC1a 
knockout ont montré une augmentation de l’allodynie thermique dans le modèle de la « plaque chaude » à trois différentes 
températures (49, 52, 55°C) comparé aux souris de type sauvage. Au contraire, Les souris ASIC2 knockout ont montré une 
diminution de l’allodynie thermique dans le modèle de la « plaque chaude » comparé aux souris de type sauvage aux trois 
mêmes températures. 
Nous concluons que les ASIC1a et les ASIC2 dans les souris peuvent jouer un rôle dans la sensation de la température. On ne 
comprend actuellement pas comment les ASICs sont impliqués dans la sensation de température et quelles sont les raisons 
des effets opposés dans les deux modèles knockout. 
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Résumé à un large public 
Rôle des canaux sensibles à l’acidification (ASICs) dans la sécrétion périphérique de neuropeptides et 
dans la douleur 
Les neurones sont les principales cellules du système nerveux. Leur fonction principale est la 
transmission de signaux. Cette signalisation se fait grâce au passage d’ions (particules chargées) à 
travers des canaux présents dans la membrane plasmique, qui délimite la cellule. Ces canaux sont 
généralement fermés et peuvent s’ouvrir après avoir été stimulés. Je me suis principalement intéressé à 
un canal nommé ASIC. Ce canal est normalement fermé et s’ouvre quand l’environnement devient 
acide. L’ouverture du canal ASIC permet d’activer les neurones. Les ASICs ont un rôle dans 
l’apprentissage, l’expression de la peur, dans la mort neuronale après une attaque cérébrale, et dans la 
sensation de douleur. Lors d’une blessure, une inflammation se produit. Elle est accompagnée d’une 
acidification qui va activer les ASICs et permettre la transmission d’un message de douleur au 
cerveau. 
Lors de ma thèse, j’ai étudié le rôle des ASICs dans les neurones sensoriels lors d’une acidification 
périphérique. Nous avons formulé l’hypothèse que ces neurones peuvent sécréter des médiateurs qui 
peuvent induire ou maintenir l’inflammation. Afin de vérifier cette hypothèse, j’ai vérifié, chez le rat, 
si les canaux ASICs étaient présents dans les mêmes neurones sensoriels que ces médiateurs. J’ai aussi 
vérifié si l’activation des ASICs par une acidification permet l’entrée de calcium dans la cellule. Nous 
savons que cette entrée de Ca
2+
 est nécessaire pour la sécrétion. Finalement, j’ai vérifié si l’activation 
des ASICs permet la sécrétion des médiateurs importants pour l’inflammation. Des expériences de 
marquage des ASICs et des médiateurs m’ont permis de montrer qu’ils étaient présents dans les 
mêmes neurones. Des expériences d’imagerie m’ont permis de montrer que l’activation des ASICs 
permet une entrée de calcium dans les neurones. Des expériences de sécrétion de médiateurs m’ont 
permis de montrer que les canaux ASICs ne sont pas impliqués dans la sécrétion ce ces médiateurs. 
J’ai pu mettre en évidence qu’un autre canal appelé TRPV1, lui aussi activé par une acidification, était 
responsable de cette sécrétion.  
Je me suis aussi intéressé au rôle possible des ASICs dans la douleur neuropathique. La douleur 
neuropathique est une douleur chronique qui apparait lors d’une lésion d’un nerf lors d’une maladie ou 
suite à un accident. Il avait été précédemment observé dans notre groupe de recherche que lors d’une 
lésion du nerf sciatique provoquant une douleur neuropathique chez le rat, des changements de ses 
canaux ASICs avaient lieu. C’est pourquoi j’ai étudié le rôle des ASICs dans la perception de la 
douleur neuropathique après une lésion du nerf sciatique chez la souris. Pour ce faire j’ai utilisé trois 
différents types de souris chez qui, à chaque fois, une différente forme d’ASIC avait été supprimé. J’ai 
comparé à chaque fois la douleur ressentie après la lésion du nerf par une souris ne possédant pas une 
certaine forme d’ASIC avec la douleur ressentie par une souris normale. J’ai pu montrer que deux 
formes d’ASICs n’avaient pas de rôle dans la douleur perçue par les souris, Les souris ne possédant 
pas une variante spécifique d’ASICs ressentaient un peu moins de douleur que les souris normales, ce 
qui nous indique, bien que les effets soient petits, que cette variante du canal est impliquée dans cette 
forme de douleur.  
Ces résultats confirment un rôle des ASICs dans l’activité des neurones sensoriels et dans la douleur, 
notamment un rôle, quoi que limité, dans la douleur neuropathique. 
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1. Introduction 
1.1 The peripheral nervous system 
1.1.1 General organization 
The somatic sensory system mediates a range of sensations: touch, pressure, vibration, limb position, 
heat, cold, and pain. These sensations are transduced by receptors at the membrane of the terminal 
endings of the axons, localized in the skin, organs, and muscles. The cell bodies of sensory neurons 
are localized in a series of ganglia that lie alongside the spinal cord and the brainstem and are 
considered part of the peripheral nervous system (PNS). Neurons in the dorsal root ganglia (DRG) and 
in the cranial nerve ganglia transmit information on peripheral events to the central nervous system 
(CNS) and ultimately the brain. Action potentials generated in afferent fibers by the activation of 
different receptors at the peripheral endings propagate along the axons to the central endings, passing 
the cell bodies located in ganglia. The central endings make synapses with central neurons in the 
spinal cord.  
The fundamental mechanism of sensory transduction, defined as the process of converting a stimulus 
into an electrical signal, can be described as a stimulus that alters the permeability of channels in the 
afferent nerve endings, generating a transmembrane potential difference called receptor potential. If 
the magnitude of the depolarization is sufficient and reaches a threshold, action potentials are 
generated along the axon toward the other ending of the axon. The rate of action potential firing is 
more or less proportional to the amplitude of the depolarization. Endings of afferent fibers can be 
encapsulated by specialized receptor cells (mechanoreceptors) that act as sensors of the somatic 
stimulations. Afferent fibers that do not have these specialized cells have free nerve endings. The free 
nerve endings have a role in the detection of painful stimuli.  
Distinct classes of afferents can be defined, each of which making unique contributions to somatic 
sensations. Sensory afferents can be classified according to their axon diameter. Sensory afferents with 
the largest diameter (called Ia) are those that are linked to the sensory receptors in the muscles. 
Sensory afferents with smaller diameter fibers (Aβ) mediate the touch sensation. Medium diameter 
myelinated (Aδ) afferents that mediate acute, well-localized “first” or fast pain differ considerably 
from the larger diameter and rapidly conducting Aβ fibers that respond to innocuous mechanical 
stimulation. Information about pain and temperature is mediated by even smaller diameter fibers (Aδ 
and C). Aδ and C fibers have a higher threshold than Aβ fibers. Small diameter unmyelinated “C” 
fibers convey poorly localized, “second” or slow pain (Figure 1). The diameter of the fibers 
determines the speed of conduction. The larger is the diameter of the fibre, the faster is the speed of 
conduction (Basbaum et al., 2009).  
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There are two major classes of nociceptors (Basbaum et al., 2009). The Aδ nociceptors can be 
subdivised into two main classes. Type I respond to both mechanical and chemical stimuli but have 
relatively high heat thresholds (>50°C). The type I fiber mediates the first pain provoked by intense 
mechanical stimuli. They will be sensitized in the case of tissue injury. Sensitization is defined as a 
lowering of the heat or mechanical threshold of response. Type II fibers have a much lower heat 
threshold, but a very high mechanical threshold. Activity of these afferents mediates the first acute 
pain to noxious heat. The unmyelinated C fibers are also heterogenous. Most C fibers are polymodal; 
they include a population that is both heat- and mechanically sensitive (Perl, 2007). 
 
Figure 1 : Description of small-diameter (Aδ), medium- to large-diameter (Aα,β) myelinated afferent fibres and small-
diameter unmyelinated afferent fibres (C) 
(Julius and Basbaum 2001)  
Another feature of sensory afferents is the size of the receptive field. The receptive field of a sensory 
neuron is defined as the area of the skin surface over which stimulation results in a significant change 
in the rate of action potentials of that neuron. The size of the receptive field is dependant of the 
innervation of the skin. The receptive fields in regions with dense innervation (lips, fingers) are 
relatively small compared to those in the forearm or back that are innervated by a smaller number of 
afferent fibers. Sensory afferents are also differentiated by the temporal dynamics of their response to 
sensory stimuli. Some afferents, which are called rapidly adapting, fire rapidly when a stimulus is first 
presented, and afterwards stop firing in the presence of continued stimulation. Other afferents generate 
a sustained discharge in the presence of continuous stimulus. Rapidly adapting afferents are 
particularly effective to provide information about stimulations that are changing, such as those 
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produced by stimulus caused by movements. In contrast, slowly adapting afferents provide 
information about the spatial attributes of the stimulus, such as size and shape (Purves, 2008). 
1.1.2 Distinct types of pain 
According to The International Association for the Study of Pain, pain is defined as "an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage". Indeed, pain is a multidimensional sensory experience that is intrinsically 
unpleasant and associated with hurting and soreness. It may vary in intensity (mild, moderate, or 
severe), quality (sharp, burning, or dull), duration (transient, intermittent, or persistent), and referral 
(superficial or deep, localized or diffuse). Pain has also strong cognitive and emotional components 
which can be described as suffering. Several distinct types exist: nociceptive, inflammatory which are 
adaptive; neuropathic and functional which are maladaptive. Adaptive pain is very useful for an 
organism to be protected against injury or to promote healing when the injury has occurred. 
Maladaptive pain, in contrast, occurs under pathological state of the nervous system. This type pain is 
considered as a disease. The sensory experience of acute pain caused by a noxious stimulus is 
mediated by the nociceptive system. Functional pain is due to an abnormal responsiveness or function 
of the nervous system. Several diseases cause this type of pain such as for example, fibromyalgia or 
irritable bowel syndrome. To prevent damage to tissue, we have learned to associate noxious stimuli 
with danger that must be avoided. We have linked noxious stimuli with pain, an unpleasant sensation. 
If tissue damage occurs despite the nociceptive defensive system, the body needs to protect itself 
against noxious, potentially damaging stimuli to promote healing of the injured tissue. The goal of the 
inflammatory pain is to allow the body to recover from the injury by increasing the sensitivity of the 
injured part until repair is complete, minimizing further damage. Maladaptive pain is uncoupled from 
a noxious stimulus or healing tissue. Such pain may occur in response to damage to the nervous 
system (neuropathic pain) or result from abnormal operation of the nervous system (functional pain). 
Neuropathic pain may result from lesions to the peripheral nervous system, as for example in patients 
with diabetic polyneuropathy, or to the central nervous system, such as for example in patients with 
multiple sclerosis or spinal cord injury (Woolf, 2004). 
1.1.3 The nociceptors 
Intense thermal, mechanical, or chemical stimuli are detected by a subpopulation of peripheral nerve 
fibers, called nociceptors. The process of detection of these stimuli by the nociceptors is called 
nociception. The cell bodies of nociceptors innervating the body are located in the DRG. The cell 
bodies innervating the face are located in the trigeminal ganglion. These neurons are pseudo-unipolar 
and they have both peripheral and central axonal branches that innervate respectively their target organ 
and the spinal cord. Nociceptors are excited only when stimulus intensities reach the noxious range.  
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Neuroanatomical and molecular characterization of nociceptors has demonstrated their heterogeneity, 
especially for the C fibers (Snider & McMahon, 1998). For example, the peptidergic population of C 
nociceptors releases the neuropeptides substance P (SP) and calcitonin-gene related peptide (CGRP); 
this population also expresses the TrkA neurotrophin receptor, which responds to nerve growth factor 
(NGF). The nonpeptidergic population of C nociceptors expresses the cRet neurotrophin receptor 
which is activated by glial-derived neurotrophic factor (GDNF). Almost all the nociceptors of the 
nonpeptidergic population bind Griffonia simplicifolia isolectin B4 (IB4) and express specific 
purinergic receptor subtypes, one of the most important being P2X3 (Basbaum et al., 2009). 
Nociceptors can also be distinguished according to their differential expression of channels that confer 
sensitivity for example to heat (TRPV1), cold (TRPM8), extracellular acidification (ASICs, TRPV1), 
or chemical irritants (TRPA1) (Julius & Basbaum, 2001). The majority of proteins synthesized by the 
DRG or trigeminal ganglion cells are distributed to both central and peripheral terminals, due to the 
particular pseudo-unipolar morphology of these neurons. The biochemical equivalency of central and 
peripheral terminals means that the nociceptors can send and receive messages from either ends 
(Basbaum et al., 2009). 
1.1.4 Projections of afferent fibers in the spinal cord 
Primary afferent nerve fibers project to the dorsal horn of the spinal cord. The dorsal horn has a 
precise laminar organisation characterized by distinct anatomical localization (Figure 2). Aδ 
nociceptors project to lamina I as well as to the deeper dorsal horn (lamina V). The Aβ fibers, which 
respond to light touch, project to the deep laminae (III, IV, and V).  
 
Figure 2 : Connections between primary afferent fibers and the dorsal horn 
(Basbaum et al., 2009) 
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The nonpeptidergic C fibers terminate in the mid-region of lamina II. The most ventral part of lamina 
II, which is characterized by the presence of excitatory interneurons, is targeted predominantly by 
myelinated nonnociceptive afferents. Spinal cord neurons within lamina I are generally responsive to 
noxious stimulation (via Aδ and C fibers), neurons in laminae III and IV are primarily responsive to 
innocuous stimulation (via Aβ), and neurons in lamina V receive a convergent nonnoxious and 
noxious input via direct, monosynaptic, Aδ and Aβ inputs and indirect (polysynaptic) C fiber inputs. 
Projection neurons within laminae I and V constitute the major output from the dorsal horn to the 
brain. These neurons are at the origin of multiple ascending pathways. One of them is the 
spinothalamic tract, which carries pain messages to the thalamus and is particulary relevant to the 
sensory-discriminative aspects of the pain experience, that is, where is the stimulus and how intense is 
it. Another is the spinoreticulothalamic tract, which carries pain to the brainstem and may be more 
relevant to poorly localized pain. From these brainstem and thalamic loci, information reaches cortical 
structures. There is no single brain area essential for pain. Rather, pain results from activation of a 
distributed group of structures, some of which are more associated with the sensory-discriminative 
properties (such as the somatosensory cortex) and others with the emotional aspects (such as the 
anterior cingulated gyrus and insular cortex). Pain results from activation of a distributed group of 
structures, some of which are more associated with the sensory-discriminative properties and others 
with the emotional aspects. Imaging studies on healthy subjects with experimental pain models or on 
patients with clinical pain conditions have demonstrated activation of prefrontal cortical areas, as well 
as regions not generally associated with pain processing (such as the basal ganglia and cerebellum). 
(Basbaum et al., 2009) 
1.1.5 Effects of a peripheral injury on nociception 
1.1.5.1 Sensitization 
Nociceptors do not only signal acute pain, but also contribute to persistent and pathological pain 
conditions that occur in the case of injury. Allodynia is defined as a pain induced by a stimulus which 
normally does not provoke pain. Allodynia can result from two different conditions: increased 
excitability of postsynaptic neurons in the dorsal horn following high levels of activity in the 
nociceptive afferents (central sensitization), or lowering of nociceptor activation thresholds (peripheral 
sensitization) (Purves, 2008). With central sensitization, pain can be produced by activity in non-
nociceptive primary sensory fibres. Peripheral sensitization results from the exposure of nociceptor 
terminals to products of tissue damage and inflammation, referred to as the “inflammatory soup” 
(Basbaum et al., 2009) (Figure 3).  
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Figure 3 : The molecular complexity of the primary afferent nociceptor is illustrated by its response to inflammatory 
mediators released at the site of tissue injury.  
(Julius & Basbaum, 2001) 
These compounds include extracellular protons, arachidonic acid and other lipid metabolites, 
serotonin, bradykinin, nucleotides and NGF, all of which can interact with receptors or ion channels 
on sensory nerve endings, increasing their response.  
1.1.5.2 Neurogenic inflammation 
Nociceptors conduct information not only in an afferent way toward the spinal cord, but also in an 
efferent way. Electrical activity of nociceptors due to the activation of terminals by local 
depolarization, axonal reflexes or dorsal horn reflexes, can release peptides and neurotransmitters (for 
example, SP, CGRP and ATP) from their peripheral terminals. An axonal reflex results from a 
stimulus applied to one branch of a nerve, which creates an impulse that moves centrally to the point 
of division of the nerve, where it is reflected down other branches to the free termini innervating, for 
example, the skin. These released factors are able to facilitate production of the inflammatory soup by 
promoting the release of factors from neighbouring non-neuronal cells (release of histamine from mast 
cells) and vascular tissue (vasodilatation, plasma extravasation), a phenomenon known as neurogenic 
inflammation (Julius & Basbaum, 2001).  
1.1.5.3 Inflammatory mediators 
NGF is produced in the setting of tissue injury and constitutes an important component of the 
inflammatory soup. NGF acts directly on peptidergic C fiber nociceptors, which express the NGF 
receptor tyrosine kinase, TrkA (Chao, 2003). NGF produces hypersensitivity to heat and mechanical 
stimuli through two different mechanisms. Rapidely after its release, NGF binds to its receptor, TrkA 
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activating downstream signaling pathways, including phospholipase C (PLC), mitogen-activated 
protein kinase (MAPK), and phosphoinositide 3-kinase (PI3K). It results in potentiation of target 
proteins at the peripheral nociceptor terminal, most notably TRPV1, leading to a rapid change in 
cellular and behavioral sensitivity (Chuang et al., 2001). Later, NGF is retrogradely transported to the 
nucleus of the nociceptor, where it promotes increased expression of substance P, TRPV1 and Nav1.8 
(Chao, 2003). These changes in gene expression enhance excitability of the nociceptor and amplify the 
neurogenic inflammatory response. Injury promotes the release of numerous cytokines as interleukin-
1β (IL-1β) and IL-6, and tumor necrosis factor α (TNF-α). Their main contribution to pain 
hypersensitivity is to potentiate the inflammatory response and increase the production of proalgesic 
agents (such as prostaglandins, NGF, bradykinin, and extracellular protons) (Basbaum et al., 2009). In 
inflammatory conditions proinflammatory mediators NGF, serotonin, interleukin-1, and bradykinin 
increase ASIC transcript levels in vivo. If applied together, these mediators are able to increase the 
amplitude of the ASIC-like currents on sensory neurons as well as the number of ASIC-expressing 
neurons. These proinflammatory mediators increase sensory neuron excitability (Mamet et al., 2002). 
α-eudesmol inhibits the presynaptic ω-agatoxin IVA-sensitive (P/Q-type) Ca2+ channels. Treatment 
with α-eudesmol dose-dependently attenuated neurogenic vasodilation in facial skin following 
electrical stimulation of rat trigeminal ganglion. α-eudesmol concentration-dependently inhibits the 
depolarization-evoked CGRP and SP release from sensory nerve terminals in spinal cord slices 
(Asakura et al., 2000). The activation of TRPV1 receptors on sensory fibers produces calcium and 
sodium influx and the release of neuropeptides (Richardson & Vasko, 2002). 
1.2 The Acid-Sensing Ion Channels (ASICs) 
1.2.1 The ENaC/degenerin family 
At the beginning of the 1990’s, a new class of ion channels was identified. This new class is now 
known as the epithelial sodium channel (ENaC)/degenerin family. The first members of this family 
were discovered in a genetic screen of the mechanosensory pathway of Caenorhabditis elegans. 
Mutations in the deg-1 gene induced a selective degeneration of the sensory neurons responsible for 
the light touch sensitivity (Chalfie et al., 1993). This phenotype has given the name “degenerin” to this 
family of channels. At about the same time, the α-subunit of ENaC was cloned (Canessa et al., 1993). 
ENaC plays a crucial role in Na
+
 reabsorption in the kidney. The amino acid sequence identity 
between the different ENaC/DEG subfamilies is about 15 to 20%. Based on their homology, a 
subfamily of neuronal channels was identified. It later appeared that these channels were activated by 
extracellular acidifications. They were consequently named Acid-Sensing Ion Channels (ASICs) 
(Waldmann et al., 1997; Waldmann & Lazdunski, 1998). Another subfamily within the ENaC/DEG 
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family of ion channels was also cloned at that time, the FMRF-amide-gated ion channel (FaNaC) 
(Lingueglia et al., 1995), which is present in the mollusc Helix aspersa (Kellenberger & Schild, 2002). 
1.2.2 Genes and splice variants 
Four different ASIC genes were identified; two of them exist in different splice variants. The ASIC1 
gene has two splice variants (-1a, -1b), as the ASIC2 gene (-2a, -2b) (Kellenberger & Schild, 2002). 
The expression of the members of this new subfamily was analysed by Northern blotting and in situ 
hybridisation (Waldmann & Lazdunski, 1998; Biagini et al., 2001) and shows a high expression in the 
central and peripheral nervous system. These channels were found to be non-voltage-activated sodium 
channels that are transiently activated by a rapid extracellular acidification (Figure 4) (Waldmann et 
al., 1997).  
 
Figure 4 : Macroscopic inward current of ASIC1a recorded at -70 mV after rapid pH change from 7.4 to 6 in Xenopus 
oocytes. 
(Waldmann et al., 1997) 
ASIC1a, -1b, -2a and -3 can form functional homomultimeric as well as heteromultimeric channels 
(Hesselager et al., 2004). ASIC2b needs to be coexpressed with ASIC1a, -1b, -2a or -3 to generate a 
proton-induced current (i.e. a current whose properties are different compared to the homomeric 
channel formed by the coexpressed subunit) (Lingueglia et al., 1997). ASIC4 is not activated by 
protons and does not form functional channels with other ASIC subunits (Grunder et al., 2000).  
1.2.3 Structure 
In 2007, the first crystal structure of ASIC was released by the group of Gouaux (Jasti et al., 2007). 
They managed to crystallize a truncated version of chicken ASIC1 (cASIC1), lacking the two N- and 
C- endings of the protein. The previously predicted secondary structure was confirmed. Each ASIC 
subunit is composed of two intracellular endings, two transmembrane domains and a large 
extracellular loop (Figure 5). Although numerous biochemical experiments done on ENaC have shown 
that it has four subunits (Firsov et al., 1998; Kosari et al., 1998), the crystal structure of cASIC1 
shows surprisingly a trimeric architecture. The transmembrane domain of ΔASIC1 is defined by two 
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long α-helices from each of the three subunits. Surrounding the “wrist”-like junction between the 
transmembrane and extracellular domains are well ordered 'loops' that probably have a key role in 
coupling conformational changes in the extracellular domain to the ion channel pore. Shaped like a 
funnel, the trimeric extracellular domain is composed of a core of three large β-sheets, one per subunit, 
and decorating this central core are three smaller β-sheet and α-helical domains (Jasti et al., 2007). 
More recently, the same group managed to crystallize a functional ASIC by keeping the N-termini of 
the protein intact. This structure is identical to the first structure in the extracellular parts, and shows a 
more realistic configuration of the transmembrane parts (Gonzales et al., 2009). 
 
Figure 5 : Structure of chicken ASIC1 
View of the homotrimeric ΔASIC1 structure. Each crystallographically independent subunit is in a different colour, a single 
chloride ion per subunit is shown as a green sphere and N-linked carbohydrate is shown in stick representation. The ΔASIC1 
structure has a chalice-like shape with a large extracellular domain protruding as much as 80 Å from the membrane plane, a 
slender transmembrane domain, and a broadened 'base' defined by the cytoplasmic N and C termini. The transmembrane 
domain of ΔASIC1 is defined by two long α-helices from each of the three subunits. On the cytoplasmic side of the 
membrane, the termini are frayed and we do not see well-ordered protein structure (Jasti et al., 2007). 
1.2.4 Biophysicals properties 
ASIC channels are activated by a drop of the extracellular pH. The selectivity ratio for Na
+
 over K
+
 is 
around 10 (Kellenberger & Schild, 2002). Homomeric ASIC1a is also slightly permeant to Ca
2+ 
(PNa
+
/PCa
2+
 = 18:1), contrary to other ASIC assemblies that are not Ca
2+
 permeant (Bassler et al., 
2001). To determine the pH dependence of activation, step pH changes from pH 7.4 to acidic solutions 
of different pH are performed. The mesured current can be plotted as a function of the activating pH 
and fitted with a Hill equation. The Hill equation allows calculating the pH50 which is the pH that 
induces half of the maximal current. The pH50 measured at 25°C in CHO cells expressing homomeric 
ASICs is 6.6 for ASIC1a, 6.2 for ASIC1b, 4.0 for ASIC2a and 6.7 for ASIC3 (Blanchard & 
Kellenberger, 2011). All functional ASICs respond to extracellular acidification with a transient 
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current. ASIC3-containing homo- and heteromultimers produce currents with a sustained phase in 
addition to the transient phase. Due to inactivation, prolonged exposure to a slightly acidic pH can 
render ASICs non-responsive to a subsequent acidic stimulus. In voltage-gated Na
+
 channels (Nav), 
this analogous property is called steady-state inactivation (SSI). The SSI represents the direct 
transition from the closed to the inactivated state during prolonged exposure to moderately acidic pH. 
For ASIC1a, the pH of half-maximal inactivation is about 7.2. Therefore, at pH more acidic than pH 
7.4, an increasing fraction of ASIC1a channels is in the inactivated conformation from which they 
cannot be opened by acidification. SSI determines the fraction of channels that are available for 
opening. ASIC activation can be important for the neuronal signalling. For example, it has also been 
shown that ASICs can induce action potentials (AP) in hippocampal neurons. The probability of 
inducing APs correlates with current entry via ASICs. The type of electrical response of a neuron to 
acidification depends on the variation of the pH, on the expression level of ASICs in the neuron, and 
on the activity of the neuron at that moment (Vukicevic & Kellenberger, 2004). 
1.2.5 ASIC modulators and activators 
Until recently, no activators of ASICs other than protons were known. Recently, it has been shown 
that 2-guanidine-4-methylquinazoline (GMQ) causes persistent ASIC3 channel activation at a 
physiological pH (Yu et al., 2010) with an EC50 of about 1 mM. A snake toxin activating ASICs with 
an EC50 ≥ 10 nM has also been recently identified (Bohlen et al., 2011). All the other substances 
described in this section can only modulate the activation of ASICs by protons, but are unable to 
activate ASICs by themselves. 
1.2.5.1 Redox reagents 
ASICs are modulated by redox reagents. It has been shown that the reducing agent dithiothreitol 
(DTT) at 1-2 mM reversibly potentiates proton-activated currents in the sensory ganglia and 
hippocampal neurons of rat, while the oxidizing reagent 5,5′-dithio-bis-(2-nitrobenzoic acid) (DTNB) 
at 5 mM causes their inhibition. The antioxidant tripeptide glutathione (its reduced form, g-l-glutamyl-
l-cysteinyl-glycine, GSH) at 2 mM also potentiates proton-activated currents (Andrey et al., 2005). 
Mouse cortical application of the reducing agents potentiated, whereas the oxidizing agents inhibited 
the ASIC currents, but no effect was seen on ASIC1 knock-out mice. Experiments done on CHO cells 
expressing homomeric ASICs have shown that ASIC1a, but not ASIC1b, -2a, -3 respond to redox 
agents (Chu et al., 2006). The effect of DTT on hASIC1a was mimicked by the metal chelator TPEN, 
indicating that the effect of DTT could be due to relief of tonic inhibition by transition metal ions, in 
addition of the redox modulation (Cho & Askwith, 2007). 
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1.2.5.2 Divalent cations: Ca2+, Zn2+ and Mg2+ 
ASICs are modulated by Ca
2+
, Zn
2+
 and Mg
2+
. Extracellular, divalent cations like Ca
2+
 and Mg
2+
 shift 
the steady-state inactivation of ASIC1a and ASIC1b to more acidic values, leading in some cases to a 
potentiation of the channel response which extends the dynamic range of ASIC H
+
 sensors. (Babini et 
al., 2002). At higher concentrations, Ca
2+
 inhibits ASIC1a partially by a pore block with an IC50 of 
about 3.9 mM at pH 5.5, whereas ASIC1b is blocked with reduced affinity with an IC50 > 10 mM at 
pH 4.7 (Paukert et al., 2004). The ASIC2a homomeric current is partially inhibited by high Ca
2+
 
concentration (de Weille & Bassilana, 2001). On ASIC3, decreasing [Ca
2+
] opens the channel because 
it is thought that protons open ASIC3 releasing Ca
2+
 from a high-affinity binding site on the 
extracellular side of the pore. The bound Ca
2+
 could block permeation and the channel could only 
conduct current when multiple protons relieve this block. (Immke & McCleskey, 2003). Zn
2+
 at 100–
300 μM concentration potentiates the acid activation of homomeric and heteromeric ASIC2a-
containing channels (i.e. ASIC2a, ASIC1a+2a, ASIC2a+3), but not of homomeric ASIC1a and ASIC3 
(Baron et al., 2001). On hippocampal neurons in primary culture, either low extracellular [Ca
2+
] or 
high extracellular [Zn
2+
] increased the amplitude of the ASIC-like currents (Gao et al., 2004). Zn
2+
 
inhibits ASIC currents in cultured mouse cortical neurons at nanomolar concentrations. At nanomolar 
concentrations, Zn2+ inhibits currents mediated by homomeric ASIC1a and heteromeric ASIC1a-
ASIC2a channels expressed in CHO cells, without effect on homomeric ASIC2a and ASIC3 (Chu et 
al., 2004). 
1.2.5.3 FMRFamide and FMRFamide-related peptides 
FMRFamide (Phe-Met-Arg-Phe amide) and related peptides are abundant in invertebrate nervous 
systems and can act as neurotransmitters and neuromodulators (Cottrell, 1989). FRMFamide is not 
expressed in mammals, but related peptides are expressed in the mammalian nervous system. It has 
been shown in various snail species that FMRFamide directly gates sodium channels called FaNaC 
(FMRFamide-activated Na+ channel) (Green et al., 1994). The structural similarity between ASICs 
and FaNaC led to test the effect of FMRFamide peptides on ASICs. Inflammation induces expression 
of FMRFamide-related neuropeptides, which modulate pain. Neuropeptide FF at 50 μM (NPFF, Phe-
Leu-Phe-Gln-Pro-Gln-Arg-Phe amide) and FMRFamide at 50–100 μM generated no current on their 
own but potentiated H+-gated currents from cultured sensory neurons and heterologously expressed 
ASIC1 and ASIC3, but not ASIC2a (Askwith et al., 2000). The heteromeric channel ASIC3 + 2a is 
even more sensitive to NPFF than to FMRFamide (Catarsi et al., 2001). Knockout mice have 
demonstrated that ASIC3 plays a major role in mediating the sensory response to FMRFamide and 
FRRFamide. Deletion of ASIC3 attenuated the response to FMRFamide-related peptides, whereas the 
loss of ASIC1 increased the response. The loss of ASIC2 had no effect on FMRFamide-dependent 
enhancement of H-gated currents. (Xie et al., 2002; Xie et al., 2003). ASIC2a is able to increase the 
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response to peptides in heteromeric channels containing ASIC1a or ASIC3 subunits (Catarsi et al., 
2001; Askwith et al., 2004; Lingueglia et al., 2006). Exogenous and endogenous FMRFamide-related 
peptides at 50 μm decreased the pH sensitivity of ASIC1a steady-state desensitization. During 
conditions that normally induced steady-state desensitization, these peptides enhanced ASIC1a 
activity (Sherwood & Askwith, 2008). Endogenous mammalian RFamide peptides such as NPFF, 
NPAF and NPSF are mainly expressed in the CNS, with high level in the spinal cord, where they can 
be released. NPFF is present in small and medium DRG neurons. NPFF has been implicated in a 
variety of physiological functions such as pain modulation and is increased in the spinal cord during 
chronic inflammation. FMRFamide-related peptides could have neuromodulatory effects, like the 
modulation of nociceptive responses on central and peripheral neurons, through their interaction with 
ASICs. This could have an important role in conditions such as chronic inflammation where the 
expression levels of both NPFF and ASICs are increased (Lingueglia et al., 2006).  
Dynorphin A at 50 μM and big dynorphin at 50 μM inhibit steady-state desensitization of ASIC1a and 
acid-activated currents in cortical neurons. Dynorphin potentiation of ASIC1a current is abolished in 
the presence of PcTx1, a specific inhibitor of homomeric ASIC1a. This suggests that dynorphins 
interact with ASIC1a to enhance channel activity. The neuroprotection induced by steady-state 
desensitization of ASIC1a is abolished in the presence of dynorphins. In other words, dynorphins 
enhance neuronal damage following ischemia by preventing steady-state desensitization of ASIC1a 
(Sherwood & Askwith, 2009). 
1.2.5.4 Serine proteases 
Ischemia or inflammation can induce an acidification of the extracellular milieu. This acidification is 
often accompanied with an increase in the activity of proteases. Serine proteases modulate the function 
of ASIC1a and ASIC1b but not of ASIC2a and ASIC3. Protease exposure shifts the pH dependence of 
ASIC1a activation and steady-state inactivation to more acidic pH. Exposing ASIC1a to serine 
proteases at physiological pH decreased the response to an acidic pH, compared to naive ASIC1a. 
Interestingly, the same experiment with a conditioning pH of 7.0 instead of 7.4 showed that the 
exposed ASIC1a is more activated than the unexposed (Poirot et al., 2004). This regulation of ASIC 
function by serine proteases is linked to channel cleavage. Trypsin, a serine protease, cleaves ASIC1a 
with a similar time course as it changes ASIC1a function, whereas ASIC1b, whose function is not 
modified by trypsin, is not cleaved. Trypsin cleaves ASIC1a at Arg-145, in the N-terminal part of the 
extracellular loop (Vukicevic et al., 2006). The closely related channel ENaC is responsible for Na
+
 
transport in many epithelia, including kidney and lung. Many factors have a role in regulating ENaC 
activity. The first evidence of a role of proteases in the regulation of ENaC was shown in a Xenopus 
kidney epithelial cell line (A6). Exposure of the apical membrane to the protease inhibitor aprotinin 
reduced transepithelial sodium transport. CAP1, a serine protease expressed in kidney, gut, lung, skin 
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and ovary, increased the activity of the sodium channel by two- to threefold (Vallet et al., 1997). 
Proteolysis of ENaC subunits has a key role in this process (Hughey et al., 2007). ENaC is composed 
of three subunits (α, β, and γ). The α and γ subunits of ENaC are processed by proteases (Hughey et 
al., 2003). Specific proteases have been shown to activate epithelial Na
+
 channels by cleaving channel 
subunits (Kleyman et al., 2009). 
1.2.6 Pharmacology 
1.2.6.1 Amiloride and benzamil 
ASICs are reversibly inhibited by amiloride and its derivative benzamil. The concentration at which 
only half of the maximal current remains (IC50) is about 10 to 100 µM depending on ASIC subunits 
(Kellenberger & Schild, 2002). It is supposed, based on experiments done on ENaC, that amiloride 
blocks ion permeation through the channel pore (Schild et al., 1997). 
1.2.6.2 Nonsteroid anti-inflammatory drugs (NSAIDs) 
Nonsteroid anti-inflammatory drugs (NSAIDs) are drugs acting against inflammation and pain. Their 
principal mode of action is to inhibit cyclooxygenases (COXs). NSAIDs prevent the large increase of 
ASIC expression in sensory neurons induced by inflammation. NSAIDs such as aspirin (500 μM), 
diclofenac (200 μM), and flurbiprofen (500 μM) directly inhibit ASIC currents in sensory neurons and 
heterologous cell expression systems (Voilley et al., 2001). It was also shown that diclofenac (IC50 of 
about 600 μM) and ibuprofen (IC50 of about 3.5 mM) inhibited proton-induced currents in 
hippocampal interneurons and that aspirin (500 μM) and salicylic acid (500 μM) were ineffective 
(Dorofeeva et al., 2008). The possible differences of expression of ASICs subunits in DRG neurons 
and in hippocampal interneurons might explain the opposite effects of aspirin and salicylic acid on 
ASIC currents found by these two groups. 
1.2.6.3 A-317567 
A-317567 produced concentration-dependent inhibition of all pH 4.5-evoked ASIC currents in acutely 
dissociated adult rat DRG neurons with an IC50 ranging between 2 and 30 μM. A-317567 blocked 
also the sustained phase of ASIC3-like current. With injection of Complete Freud's Adjuvant (CFA) in 
rat, inducing inflammatory thermal hyperalgesia, A-317567 completely inhibited the pain response at 
a 10-fold lower dose than amiloride (Dube et al., 2005). 
1.2.6.4 Psalmotoxin 1 (PcTx1) 
Psalmotoxin 1 (PcTx1) is a 40-amino acid toxin from tarantula Psalmopoeus cambridgei venom. It 
blocks with an IC50 of 0.9 nM ASIC1a homomeric channels (Escoubas et al., 2000). PcTx1 inhibits 
ASIC1a by a unique mechanism: the toxin increases the apparent affinity for H
+
 of ASIC1a. The toxin 
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shifts the inactivation curve to more alkaline pH, inactivating almost completely ASIC1a at 
physiological pH (Chen et al., 2005). 
1.2.6.5 APETx2 
APETx2 is a toxin from the sea anemone Anthopleura elegantissima, which inhibits ASIC3 
homomeric channels both in heterologous expression systems and in primary cultures of rat sensory 
neurons. APETx2 reversibly inhibits rat ASIC3 (IC50 = 63 nM), without any effect on ASIC1a, 
ASIC1b, and ASIC2a. APETx2 also inhibits heteromeric channels containing ASIC3 subunits, 
however with a lower potency. The ASIC3-like current in primary cultured sensory neurons is partly 
and reversibly inhibited by APETx2 (Diochot et al., 2004). Recently our group showed that APETx2 
inhibited the tetrodotoxin (TTX)-resistant Nav 1.8 currents of DRG neurons with an IC50 of 2.6 μM, 
meaning that this toxin is not completely specific for ASIC3. This lack of specificity should be taken 
into account when using APETx2 as a pharmacological tool (Blanchard et al., 2011). 
1.2.6.6 MitTx 
Recently, it has been shown that venom from the Texas coral snake Micrurus tener tener, whose bite 
produces intense and unremitting pain, excites a large proportion of sensory neurons. The purified 
toxins (MitTx) act as selective agonists for ASICs, showing equal or greater efficacy compared with 
acidic pH. MitTx is highly selective for the ASIC1 subtype at neutral pH; under more acidic 
conditions (pH < 6.5), MitTx potentiates (>100-fold) proton-evoked activation of ASIC2a channels 
(Bohlen et al., 2011). 
 
1.3 ASICs in the central nervous system 
1.3.1 Expression pattern 
All ASICs except ASIC1b and ASIC3 are expressed in the CNS. ASICs are distributed widely 
throughout the brain. ASIC1a, ASIC2a, and ASIC2b have a similar widespread distribution pattern in 
the brain. They are expressed in areas such as cortex, olfactory bulb, hippocampus, amygdala, and 
cerebellum (Waldmann & Lazdunski, 1998). Within cells, ASIC1 was found in almost all parts, 
including the soma and along the branches of axons and dendrites. In one study, ASIC1 was found not 
to be enriched in the microdomains where pH may reach low values, such as in synaptic vesicles or 
synaptic membranes (Alvarez de la Rosa et al., 2003). In another study, ASIC1a was found to be 
enriched in areas with strong excitatory synaptic input such as the glomerulus of the olfactory bulb, 
whisker barrel cortex, cingulate cortex, striatum, nucleus accumbens, amygdala, and cerebellar cortex 
(Wemmie et al., 2003). ASIC1 null mice had impaired hippocampal long-term potentiation and had 
reduced excitatory postsynaptic potentials during high-frequency stimulation, suggesting a 
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postsynaptic localisation of ASIC1a (Wemmie et al., 2002). This post-synaptic localisation is in 
contradiction with the previous findings done by de la Rosa et al. ASIC2a is enriched in synaptic 
fractions from cerebellum (Jovov et al., 2003).  
ASIC4 shows strongest expression in pituitary gland. Moreover, ASIC4 expression is detected 
throughout the brain, in spinal cord, and inner ear (Grunder et al., 2000). Reverse transcriptase-nested 
PCR and Western blotting showed that three ASIC isoforms, ASIC1a, ASIC2a, and ASIC2b, are 
expressed at a high level in dorsal horn neurons (Wu et al., 2004). ASIC1a and ASIC2a are the most 
abundant ASICs in mouse adult spinal cord and are coexpressed by most neurons in all the laminas 
(Baron et al., 2008). Photoreceptors and neurons of the mouse retina express ASIC2a and ASIC2b 
(Ettaiche et al., 2004).  
1.3.2 Role of ASIC1a in memory and fear 
ASIC1a null mice have impaired hippocampal long-term potentiation. ASIC1a null mice had reduced 
excitatory postsynaptic potentials and NMDA receptor activation during high-frequency stimulation. 
Null mice displayed defective spatial learning and eyeblink conditioning.  Therefore ASIC1a has a 
small role in processes underlying synaptic plasticity, learning, and memory (Wemmie et al., 2002). 
However, another study did not observe any differences in short-term plasticity upon blockade of 
ASIC1 with amiloride or inactivation of ASIC1 by lowering the conditioning pH to 6.7 in cultured 
hippocampal neurons. Protons released during intense synaptic activity did not activate postsynaptic 
ASIC1 currents in excitatory synapses and any activation of presynaptic ASIC currents did not alter 
synaptic transmission (Alvarez de la Rosa et al., 2003).  
ASIC1a modulates the activity of the circuits underlying innate fear (Wemmie et al., 2003). 
Furthermore, removing the ASIC1a gene or acutely inhibiting ASIC1a suppresses fear and anxiety 
independent of conditioning (Coryell et al., 2007). Rescue experiments, expressing ASIC1a in the 
basolateral amygdala of ASIC1a null mice using viral vector-mediated gene transfer pinpoint the 
basolateral amygdala as the site where ASIC1a contributes to fear memory (Coryell et al., 2008). 
Inhaled CO2 reduces brain pH and evokes fear behavior in mice. Using ASIC1a knock-out mice or 
inhibiting ASIC1a significantly reduced the effect of CO2. Rescuing ASIC1a specifically in the 
amygdala of ASIC1a null animals re-established the CO2-induced fear deficit. The amygdala is 
through ASIC1a an important chemosensor that detects hypercarbia and acidosis and initiates fear 
responses (Ziemann et al., 2009). 
1.3.3 Role of ASIC1a in cerebral ischemia 
ASICs in central neurons might contribute to the neuronal death associated with brain ischemia. In cell 
culture, cells lacking endogenous ASICs are resistant to acid injury, while transfection of Ca
2+
-
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permeable ASIC1a establishes sensitivity to acid. In focal ischemia, intracerebroventricular injection 
of ASIC1a blockers (amiloride, venom containing PcTx1) or knockout of the ASIC1a gene protects 
the brain from ischemic injury and does so more potently than glutamate antagonism (Xiong et al., 
2004). 
1.4 ASICs in the peripheral nervous system 
All ASIC subunits are found in the PNS. ASIC expression has also been found outside the nervous 
system in eye, ear, taste buds and bone (Wemmie et al., 2006). ASICs are expressed in all DRG 
neuron subtypes, with the subunit composition varying among DRG neurons, producing different 
types of ASIC currents in different DRG neuron populations. An electrophysiological characterization 
performed in our group proposes the following classification (Poirot et al., 2006). Small-diameter 
DRG neurones expressed three different ASIC current types which were all preferentially expressed in 
putative nociceptors. Type 1 currents are mediated by ASIC1a homomultimers and are characterized 
by steep pH dependence of current activation in the pH range 6.8–6.0. Type 3 currents are activated in 
a similar pH range as type 1, while type 2 currents are activated at pH<6. Type 1 current slowly 
inactivates at pH6, whereas type 2 and 3 inactivate rapidly. Within small-diameter neurones, two main 
subpopulations can be distinguished based on the binding of IB4. IB4-negative neurons are known to 
express neuropeptides and therefore IB4 is a marker for non-peptidergic neurons. There is evidence for 
different functions of IB4-positive and negative neurones in pain sensation (Snider & McMahon, 
1998).  
 
Figure 6 : Proportion of small IB4-negative (left) and IB4-positive neurones (right) without ASIC current (white), and 
type 1 (hatched), type 2 (black) and type 3 (cross-hatched) 
 (Poirot et al., 2006) 
  
17 
 
The correlation with ASIC currents showed first that 91% of IB4-negative, but only 36% of IB4-
positive, neurones express an ASIC current. In IB4-positive neurones expressing an ASIC current, the 
majority of the ASIC currents (70%) are of the fast inactivating types 2 and 3. About half of IB4-
negative neurones express type 1 current (Figure 6) (Poirot et al., 2006). 
1.4.1 Mechanosensation 
The similarity of ASICs to nematode proteins involved in mechanotransduction suggested that they 
might be involved in mechanosensation. In one study, disrupting the mouse ASIC2 gene markedly 
reduced the sensitivity of a specific component of mechanosensation: low-threshold rapidly adapting 
mechanoreceptors. In rodent hairy skin these mechanoreceptors are excited by hair movement. 
Consistent with this function, ASIC2 was found in the lanceolate nerve endings that lie adjacent to and 
surround the hair follicle. Thus, it was concluded that ASIC2 is essential for the normal detection of 
light touch and may be a central component of a mechanosensory complex (Price et al., 2000). 
Interestingly, another study investigated the effect of an ASIC2 gene knockout in mice on hearing and 
on cutaneous mechanosensation and visceral mechanonociception. They did not find a role of ASIC2 
in these aspects of mechanoperception. They performed the same experiments low-threshold rapidly 
adapting mechanoreceptors, but on the contrary of the previously cited study, they did not find any 
difference between ASIC2 null mice and wild type mice (Roza et al., 2004). Using ASIC2 null mice, 
it has been shown that normal ASIC2 expression is required for normal pressure-induced constriction 
in the middle cerebral arteries (Gannon et al., 2008a). ASIC2 was found to be expressed in aortic 
baroreceptor neurons in the nodose ganglia and their terminals. ASIC2 null mice developed 
hypertension, had exaggerated sympathetic and depressed parasympathetic control of the circulation, 
and a decreased gain of the baroreflex, all being a sign of an impaired baroreceptor reflex (Lu et al., 
2009).  
ASIC3 was identified in several different specialized sensory nerve endings of skin, suggesting it 
might participate in mechanosensation. Disrupting the mouse ASIC3 gene altered sensory 
transduction. Loss of ASIC3 increased the sensitivity of mechanoreceptors detecting light touch (Price 
et al., 2001).  
Because functional redundancy of ASIC subunits might explain limited phenotypic alterations, it was 
hypothesized that disrupting multiple ASIC genes would markedly impair cutaneous 
mechanosensation. In a recent study, it was found the opposite. In behavioral studies, mice with 
simultaneous disruptions of ASIC1a, -2 and -3 genes (triple-knockouts) showed increased paw 
withdrawal frequencies when mechanically stimulated with von Frey filaments. In single-fiber nerve 
recordings of cutaneous afferents, mechanical stimulation generated enhanced activity in A-
mechanonociceptors of ASIC triple-knockouts compared to wild-type mice (Kang et al., 2012). 
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1.4.2 Nociception 
As mentioned before, ASICs are localized in nociceptors and are activated by protons, one of the first 
compounds released by damaged cells during inflammation. Acidification also occurs in painful 
diseases like ischemia, hematoma, fracture, tumor development and incisions after a surgery. ASIC1a, 
-2 and -3 knockout mice have been used to elucidate the role of ASICs in different models of 
nociception.  
ASIC3 knockout mice have been reported to have a small but significant increase of sensitivity 
compared to wild-type animals in a model of mechanical hyperalgesia induced with carrageenan. After 
injection of acidic (pH 4) saline into the gastrocnemicus muscle, ASIC3 null mice had significantly 
less hyperalgesia compared to wild-type mice (Price et al., 2001). In an animal model of long lasting 
mechanical hypersensitivity produced by repeated acidic saline injection in the muscle ASIC3 null 
mice did not develop mechanical hyperalgesia, while wild-type mice did. ASIC1 null mice were also 
tested and did not show any difference compared to wild type mice (Sluka et al., 2003). In a rescue 
experiment, it has been shown that the injection into muscle, but not skin of ASIC3 null mice of 
ASIC3-encoding virus, which induce the expression of ASIC3 in primary afferent fibers innervating 
the site of injection, resulted in the development of mechanical hyperalgesia similar to that observed in 
wild-type mice. Heat hyperalgesia develops similarly in ASIC3 null and wild-types animals (Sluka et 
al., 2007). The secondary mechanical hyperalgesia that develops after knee joint inflammation, 
induced by carrageenan injection in the knee joint cavity, was not induced in ASIC3 null mice. 
However, the primary mechanical hyperalgesia was still present in ASIC3 null mice (Ikeuchi et al., 
2008). Another study showed similar results with carrageenan-induced muscle inflammation. ASIC3 
null mice develop primary muscle hyperalgesia but not secondary paw mechanical hyperalgesia after 
injection of carrageenan in the gastrocnemius muscle. In contrast, ASIC1 null mice did not develop 
primary muscle hyperalgesia but developed secondary paw hyperalgesia after carrageenan injection. 
The ASIC inhibitor A-317567, given locally, reverses both the primary and the secondary 
hyperalgesia induced by carrageenan muscle inflammation (Walder et al., 2010). Recently, it has also 
been shown that reducing in-vivo ASIC3 using artificial miRNAs inhibits both primary and secondary 
hyperalgesia after muscle inflammation in wild-type mice (Walder et al., 2011).  
In contradiction with studies cited above, a group showed that ASIC3 null mice displayed a reduced 
latency to the onset of pain response, or more pain-related behaviour, when stimuli of moderate to 
high intensity were used. This effect seemed independent of the modality of the stimulus and was 
observed in the acetic-induced writhing test, in the hot plate test, and in tail-pressure test for 
mechanically induced pain (Chen et al., 2002). Chen later found with his own group that ASIC3 null 
mice showed normal thermal and mechanical hyperalgesia with acute (4 hours) intraplantar CFA- or 
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carrageenan-induced inflammation. The hyperalgesic effects in the sub-acute phase (1-2 days) induced 
by carrageenan were milder in ASIC3 null mice for the mechanical hyperalgesia and normal for the 
thermal hyperalgesia. It was also confirmed that mechanical hyperalgesia was abolished in ASIC3 null 
mice in a model of carrageenan-induced inflammation in muscles (Yen et al., 2009). These results of 
the carrageenan injection model are in contradiction with Price et al. (Price et al., 2001) who describe 
opposite effects. Following hind paw inflammation with formalin injection, ASIC1 and ASIC2, but 
not ASIC3 null mice showed enhanced pain behaviour compared to wild type littermates, 
predominantly in the second phase of the test (Staniland & McMahon, 2008).  
An interesting approach has been used to circumvent the heteromultimerisation of ASIC subunits 
which renders difficult the understanding of single ASIC subunit knock-out mice experiments. 
Transgenic mice expressing a dominant negative form of the ASIC3 subunit have been generated. All 
native neuronal ASIC-like currents were inactivated in these mice. Both wild-type and transgenic mice 
were equally sensitive to thermal pain and to thermal hypersensitivity after inflammation. 
Surprisingly, transgenic mice were more sensitive to mechanical pain, inflammatory pain after 
formalin injection, intraperitoneal injections of acetic acid, mechanical hypersensitivity after zymosan 
inflammation, and mechanical hypersensitivity after intramuscular injection of hypotonic saline 
(Mogil et al., 2005).  
Systemic administration of amiloride produces a robust, dose-dependent blockade of late phase 
nociceptive behaviour on the mouse formalin test in female but not male mice (Chanda & Mogil, 
2006). This discrepancy between male and female has also been shown in muscle fatigue, which is 
associated with a number of clinical diseases, including chronic pain conditions. Enhanced muscle 
fatigue occurred in male but no female ASIC3 null mice (Burnes et al., 2008).  
Using rats, it has been shown that moderately acidic pH increased the excitability of nociceptors and 
that subcutaneous injections of moderately acid solutions in one of the hind paws produced pain. Both 
effects were suppressed by the toxin APETx2, a blocker of ASIC3. Both APETx2 and the in vivo 
knockdown of ASIC3 with a specific siRNA had potent analgesic effects against primary 
inflammation-induced hyperalgesia (Deval et al., 2008). From studies with rats, PcTx1 has been 
shown to possess opioid-type analgesic properties via ASIC1a channels. This means that central 
inhibition of ASIC1a, acting upstream of the opiate system, might be exploited to treat any type of 
pain (Mazzuca et al., 2007). ASIC1a was found to be the predominant ASICs in rat spinal dorsal horn 
neurons. Downregulation of ASIC1a by local spinal infusion with specific inhibitors or antisense 
oligonucleotides attenuated complete Freund's adjuvant-induced thermal and mechanical 
hypersensitivity. An increased ASIC activity in spinal dorsal horn neurons was shown to promote pain 
by central sensitization (Duan et al., 2007). In a rat model of postoperative pain involving plantar 
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incision, ASIC3 mRNA and protein levels in lumbar DRG neurons are increased 24 h after surgery. 
Pharmacological inhibition of ASIC3 with APETx2 or in vivo knockdown of ASIC3 by siRNA led to 
a significant reduction of postoperative spontaneous, thermal, and postural pain behaviours, showing a 
significant role for peripheral ASIC3-containing channels in postoperative pain (Deval et al., 2011).  
Finally, direct injection of acidic solutions (pH ≥ 6.0) into human skin caused localized pain, which 
was blocked by amiloride. Under more severe acidification (pH 5.0) amiloride was less effective in 
reducing acid-evoked pain (Ugawa et al., 2002). In another study, iontophoresis of protons was used 
to investigate acid-induced pain in human volunteers. It was found that transdermal iontophoresis of 
protons consistently caused moderate pain that was dose-dependent. Subcutaneous injection of 
amiloride significantly inhibited the pain induced by iontophoresis of acid, suggesting an involvement 
of ASICs (Jones et al., 2004). 
1.4.3 Taste and hearing 
In situ hybridisation and RT-PCR experiments revealed that ASIC2a and ASIC2b transcripts were 
localized in taste bud cells (Shimada et al., 2006). However, Ca
2+
 imaging experiments on taste bud 
cells of ASIC2 knock-out mice showed that the cells had normal physiological responses to acid taste 
stimuli (Richter et al., 2004). In human, it has been shown that ASIC1a, -1b, -2a, -2b and -3 were 
expressed in lingual fungiform papillae which contain taste cells. These transcripts were undetectable 
in two patients with an acquired sour ageusia, suggesting a role for ASICs in human sour perception 
(Huque et al., 2009). 
ASIC2 is present in the spiral ganglion neurons in the mouse adult cochlea. ASIC2 null mice showed 
no significant hearing deficit but were considerably more resistant to noise-induced temporary, but not 
permanent, threshold shifts. It suggests that ASIC2 is not directly involved in the mechanotransduction 
of the cochlea but could contribute to suprathreshold functions of the cochlea (Peng et al., 2004). 
ASIC3 has been also found in the cochlea of mice by quantitative real-time polymerase chain reaction. 
In-situ hybridisation and immunofluorescence showed that ASIC3 was expressed in the cells and in 
the neural fibre region of the spiral ganglion. ASIC3 protein was also detected in cells of the organ of 
Corti. An ASIC3 knockout mouse model was tested for a hearing loss phenotype and was found to 
have normal hearing at 2 months of age but appeared to develop hearing loss early in life (Hildebrand 
et al., 2004). It has also been shown that female ASIC3 null mice showed elevated hearing thresholds 
for low to ultrasonic frequency on auditory brain stem response. The response to pups' wriggling calls 
and ultrasonic vocalization, as well as the retrieval of pups was deficient in these mice (Wu et al., 
2009). 
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1.4.4 Molecular basis of signal detection and propagation 
The primary afferent nerve fiber detects thermal, mechanical or chemical environmental stimuli and 
transduces the information into electrical current. In the following, I describe an important class of 
channels which detect stimuli in sensory neurons and two classes of channels involved in the 
transmission of the electrical signal in the same neurons. 
1.4.4.1 ThermoTRP channels (TRVPV1, TRPV2, TRPA1 and TRPM8) 
Transient receptor potential (TRP) channels were first identified in a phototransduction mutant in 
Drosophila that showed a transient instead of a sustained response to light (Montell & Rubin, 1989). 
In this chapter, I will only focus on four members of this family which play an important role in 
stimulus detection in sensory neurons.  
Four identical TRPV1 subunits, each containing six transmembrane segments with a pore loop 
between transmembrane segments 5 and 6, assemble to form the channel (Lee & Caterina, 2005). In 
heterologous systems this channel is weakly Ca
2+
-selective, and when stimulated by capsaicin, 
resiniferatoxin, acid, endocannabinoids, or heat (>43°C), it produces outwardly rectifying cation 
currents (Caterina et al., 1997; Tominaga et al., 1998; Caterina et al., 1999). TRPV1 is expressed 
primarily in small- to medium-diameter peptidergic and nonpeptidergic sensory neurons (from Aδ and 
C fibers) within the dorsal root, trigeminal, and nodose sensory ganglia (Caterina et al., 1997; 
Tominaga et al., 1998). TRPV1-knockout mice have been generated and electrophysiological 
responses to capsaicin, acid, and heat (>43°C) were reduced or absent in these mutants. Inflammation-
induced heat hyperalgesia was virtually abolished in TRPV1 knockout animals (Caterina et al., 2000; 
Davis et al., 2000).  
TRPV2 has been found to mediate high-threshold heat sensations (>52°C) in vitro. Since it is 
expressed in medium- to large-diameter sensory neurons, it is thought to be associated with Aδ fibers 
(Caterina et al., 1999). Evidence that the TRPV2 channels mediate sensation to heat in vivo is lacking.  
TRPM8 channels are activated by menthol, icilin and by reductions in temperature from cool (<28°C) 
to noxious cold (<15°C) (McKemy et al., 2002; Peier et al., 2002; Voets et al., 2004). TRPM8 
expression is restricted to approximately 5%–10% of adult DRG neurons. TRPM8 is expressed in 
small-sized neurons (from Aδ and C fibers). TRPM8-positive neurons appear to belong to a subset of 
nociceptive or thermoceptive neurons that express tyrosine kinase receptor A (trkA), an NGF receptor, 
during development. TRPM8 is expressed in a small subpopulation of neurons distinct from the well-
characterized heat- and pain-sensing neurons expressing the markers TRPV1, CGRP, or IB4 (Peier et 
al., 2002). TRPM8 knock-out mice showed a reduced sensitivity to menthol in one study (Colburn et 
al., 2007), and were in a second study completely insensitive to menthol and icilin (Bautista et al., 
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2007). Cold analgesia after formalin injections was also evaluated on TRPM8 ko mice. On a 17°C 
cold plate, formalin-treated wild type mice displayed reduced responses compared to mice at room 
temperature during the acute and inflammatory phases of the test, demonstrating that cold is analgesic 
to formalin administration. This behaviour is completely ablated in TRPM8-deficient mice, suggesting 
that TRPM8 activation can elicit an analgesic response (Dhaka et al., 2007). TRPM8 is important for 
thermal sensitivity and contributes to responses in the cold range; however detection of noxious cold 
appears to involve additional mechanisms.  
TRPA1 is activated by cold temperature (<18°C), icilin, cannabinoids, mustard oil, as well as 
mechanical stimuli (hair cells in inner ear) (Corey et al., 2004; Wang & Woolf, 2005). Submicromolar 
to low micromolar concentrations of menthol cause TRPA1 activation, whereas higher concentrations 
lead to a reversible channel block (Karashima et al., 2007). TRPA1 is involved in nicotine-induced 
irritation. Micromolar concentrations of nicotine activated heterologously expressed mouse and human 
TRPA1. TRPA1 mediated the mouse airway constriction reflex to nasal instillation of nicotine 
(Talavera et al., 2009). TRPA1 is expressed in a small population of sensory neurons expressing 
TRPV1, CGRP, SP, but not TRPM8 (Jordt et al., 2004; Wang & Woolf, 2005). TRPA1 is not 
expressed with TRPM8, indicating that these channels do not coordinate at the level of individual 
sensory cells to integrate thermal information. Since TRPA1 is not expressed in heavily myelinated 
neurons, it has been suggested that it is localized to non-myelinated C- or lightly myelinated Aδ-fibers. 
Experiments in heterologous cells have shown that TRPA1 is stimulated by formalin (McNamara et 
al., 2007). Neurons from wild type trigeminal and dorsal root ganglia were activated also by formalin 
and the responses were blocked by a TRPA1 inhibitor (HC-030031), whereas neurons from TRPA1 
knock-out mice were unresponsive to formalin. TRPA1 appears to mediate nociceptive responses to 
formalin (Wetsel, 2011). A single point mutation in TRPA1 (N855S) has been linked with an 
autosomal-dominant familial episodic pain syndrome characterized by episodes of debilitating upper 
body pain, triggered by fasting and physical stress. The mutant channel showed altered biophysical 
properties, with a 5-fold increase in inward current on activation at normal resting potentials. Patients 
carrying this gain-of-function mutation in TRPA1 displayed an enhanced secondary hyperalgesia to 
punctate stimuli on treatment with mustard oil compared to non-affected siblings (Kremeyer et al., 
2010). Cold plate and tail-flick experiments on TRPA1 null mice revealed a TRPA1-dependent, cold-
induced nociceptive behaviour, showing that TRPA1 acts as a major sensor for noxious cold 
(Karashima et al., 2009). 
1.4.4.2 Nav channels 
Nine pore-forming sodium channel α-subunits (Nav1.1–Nav1.9) have been identified in mammals, and 
their expression is spatially and temporally regulated (Catterall et al., 2005a). These channels are large 
polypeptides that fold into four domains (DI–DIV), each domain including six transmembrane 
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segments, linked by three loops (Catterall, 2000). Recently, a Nav channel from Arcobacter butzleri 
has been crystallised. One of the new findings was that the arginine gating charges make multiple 
hydrophilic interactions within the voltage sensor, including unexpected hydrogen bonds to the protein 
backbone (Payandeh et al., 2011).  
Different channels gate with different kinetics and voltage-dependent properties, with six channels 
sensitive to block by nanomolar concentrations of tetrodotoxin (TTX), which are called TTX-sensitive 
(TTX-S), and three channels resistant to this blocker and which are called TTX-resistant (TTX-R) 
(Catterall et al., 2005a). DRG neurons can express up to five types of sodium channels, more than in 
any other neuronal cell type (Black et al., 1996; Dib-Hajj et al., 1998). Adult DRG neurons can 
express the TTX-S channels Nav1.1, Nav1.6, and Nav1.7, and the TTX-R channels Nav1.8 and Nav1.9 
(as well as Nav1.5 at low levels). Nav1.3 channels are present in embryonic, but not in adult DRG 
neurons and are re-expressed under pathological condition (Waxman et al., 1994). Nav1.1 and Nav1.6 
expression is common to central nervous system (CNS) and peripheral nervous system (PNS) neurons, 
whereas Nav1.7, Nav1.8, and Nav1.9 are specific to PNS neurons. Nav1.7 is expressed in sensory and 
sympathetic (Toledo-Aral et al., 1997), and myenteric (Sage et al., 2007) neurons, whereas Nav1.9 is 
expressed in sensory and myenteric neurons (Dib-Hajj et al., 1998; Rugiero et al., 2003), and Nav1.8 
only in sensory neurons (Akopian et al., 1996; Rugiero et al., 2003). Nav1.7, Nav1.8, and Nav1.9 may 
have evolved in a specialized sensory role in mammals, including pain (Dib-Hajj et al., 2010).  
Inherited erythromelalgia (IEM) is characterized by intense episodic burning pain associated with 
redness and warmth of the affected extremities. Several groups identified point mutations in Nav1.7 of 
patients affected with IEM (Yang et al., 2004; Dib-Hajj et al., 2005). IEM mutations of Nav1.7 have 
been shown to cause a hyperpolarizing shift in activation and slow deactivation, decreasing the 
threshold for action potential generation in sensory neurons and increasing neuronal excitability 
(Cummins et al., 2004; Fischer & Waxman, 2010).  
Some members of three consanguineous families from northern Pakistan have a complete inability to 
sense pain. These individuals carry homozygous nonsense mutations on the Nav1.7 gene causing a loss 
of function of the channel, suggesting that Nav1.7 is an essential and non-redundant requirement for 
nociception in humans (Cox et al., 2006).  
Finally, from a more pharmacological point of view, residues in the inner cavity of the channel pore 
involving the S6 segment of domains I, III, and IV form the binding site for local anesthetic drugs 
such as lidocaine, meaning that lidocaine can be used as a sodium channel blocker (Liu & Wood, 
2011). 
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1.4.4.3 Voltage-gated calcium channels (Cav) 
Certain types of voltage-gated calcium channels (Cav) can trigger the release of neuropeptide-
containing vesicules via an entry of calcium in DRG sensory neurons and dorsal horn neurons. Cav can 
be classified based on their voltage activation characteristics as high- or low-voltage activated 
channels. The Cavs can also be classified based on their structural similarities of the channel-forming 
α1-subunit (Cav1, Cav2, Cav3) or their sensitivity to blockade by pharmacological agents (L, N, P/Q, R 
and T-type). The high-Cavs include L-type (Cav1.1, Cav1.2, Cav1.3, Cav1.4), P/Q-type (Cav2.1), N-type 
(Cav2.2) and R-type (Cav2.3) channels, while the low-Cavs include T-type (Cav3.1, Cav3.2, Cav3.3) 
channels. The high-Cavs typically form heteromultimers that consist of the channel-forming α1-subunit 
along with auxiliary β-, α2δ and γ-subunits. (Catterall et al., 2005b). The α1-subunits have the same 
topology as the main Nav subunits (Yu et al., 2005). 
L-type channels are widely distributed in the central nervous system. Four different isoforms exist for 
L-type channels (CaV1.1–CaV1.4), with CaV1.2 and CaV1.3 being strongly expressed in neurons (Ertel 
et al., 2000). The 1,4-dihydropyridines are able to activate or block specifically Cav1 (L-type 
channels). Nifedipine is a Dihydropyridine which inhibits L-type channels (Triggle, 2003).  
N-type channels are expressed at high density on the presynaptic terminals of primary afferent neurons 
that terminate in the dorsal horn of the spinal cord. The modulation of both central and peripheral T-
type channels results in significant alteration of the pain threshold in some animal pain models 
(Todorovic & Jevtovic-Todorovic, 2006). The highly N-type selective ω-conotoxins MVIIA and 
CVID reduced pain behaviours in rats (Smith et al., 2002). Ziconotide, a synthetic form of ω-
conotoxin MVIIA, is used for intrathecal treatment of severe chronic pain in patients (Schmidtko et 
al., 2010). 
CaV2.1 P/Q-type channels are expressed at the presynaptic terminals in the spinal dorsal horn 
(Catterall & Few, 2008). The involvement of P/Q-type channels in pain processing is not well 
understood. P/Q-type channels show little colocalization with substance P, and treatment with ω-
agatoxin IVA, a specific inhibitor of P/Q-type channels, has no effect on the release of either 
substance P or CGRP from peptidergic sensory neurons (Evans et al., 1996; Westenbroek et al., 1998). 
ω-conotoxin MVIIC is also a specific inhibitor for the P/Q-type channels (Nielsen et al., 2000).  
In sensory pathways, T-type channels are located on primary afferent terminals and dorsal root 
ganglia, with CaV3.2 being the most abundant isoform in the DRG (Bourinet et al., 2005). The T-type 
channel subtype has one of the most prominent roles in nociception (Park & Luo, 2010). Mibefradil is 
a compound that blocks both T-type and L-type calcium channels. It blocks T-type calcium channel 
currents at a lower concentration than that needed to inhibit L-type channels (Mocanu et al., 1999). 
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1.4.5 Neuropeptides and their peripheral targets 
1.4.5.1 Calcitonin gene-related peptide (CGRP) 
CGRP is a 37–amino acid peptide that is a member of the calcitonin family, which also includes 
calcitonin, amylin, and adrenomedullin. CGRP exists in two distinct isoforms: CGRPα (CGRP1), 
which is the product of alternative splicing of the calcitonin gene in neurons, and CGRPβ (CGRP2), 
which is encoded by a separate gene (Poyner, 1992). These two CGRP peptides differ from each other 
by three amino acids and are not distinguishable in their biological activities. CGRP is widely 
expressed in the central and peripheral nervous systems. CGRP is expressed in a subset of small 
neurons in the DRG, trigeminal, and vagal ganglia. These CGRP-containing neurons are polymodal 
nociceptors that are activated by chemical, thermal and high-threshold mechanical stimuli (Tsukagoshi 
et al., 2006). These peptidergic neurons have small myelinated (Aδ) and unmyelinated (C) axons that 
innervate essentially all peripheral tissues and send primary afferent input to nociceptive and 
viscerosensitive neurons in the dorsal horn (Gu & Yu, 2007).  
CGRP and substance P are released from large dense-core vesicles. In rat trigeminal ganglia CGRP 
was found to be co-expressed with the three exocytotic SNAREs (SNAP25, syntaxin 1 and the 
synaptobrevin isoforms) and synaptotagmin. Ca
2+
-dependent CGRP release was evoked with K
+
-
depolarisation and, to lower levels, by capsaicin or bradykinin from neurons that contain TRPV1, 
respectively bradykinin receptor 2 (Meng et al., 2007). 
1.4.5.2 The CGRP Receptor 
The functional CGRP receptor consists of the assembly of a 7-transmembrane domain G protein–
coupled receptor known as calcitonin receptor-like receptor (CLR) and an associated single 
transmembrane domain protein called receptor activity-modifying protein 1 (RAMP1) (Walker et al., 
2010) (Figure 7) (Benarroch, 2011). RAMP1 is required to transport CLR to the plasma membrane, to 
present the receptor at the cell surface as a mature glycoprotein, and is essential for CGRP receptor 
signalling (McLatchie et al., 1998). The primary signal transduction pathway for the CGRP receptor is 
mediated by Gαs, which activates adenylyl cyclase, leading to the production of cyclic adenosine 
monophosphate (cAMP) and activation of protein kinase A (PKA). The CGRP-triggered cAMP-PKA 
pathway regulates the activity of various downstream signaling components, including K
+
 channels, L-
type Ca
2+
 channels, and cAMP response element binding protein. These effector mechanisms mediate 
numerous actions of CGRP, including vasodilation, neurotransmitter release, increased neuronal 
excitability, and synaptic plasticity (Walker et al., 2010). In general, the distribution of CGRP 
receptors overlaps with that of CGRP in peripheral tissues (particularly blood vessels), dorsal horn, 
trigeminal nucleus, parabrachial nuclear complex, thalamus, amygdala, striatum, and cerebellum 
(Tschopp et al., 1985; Henke et al., 1987).  
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Figure 7 : Calcitonin gene-related peptide (CGRP) receptor and transduction pathways.  
The upper panel shows the topology of RAMP1 and CLR which form the CGRP receptor. The lower panel shows the  
transduction pathway of the CGRP receptor at a neuronal plasma membrane (Benarroch, 2011). 
 
1.4.5.3 Substance  P (SP) 
SP is a neuropeptide that has, among others, a crucial role in nociceptive signal transmission. The 
history of this neuropeptide began in 1931, when Von Euler and Gaddum isolated a substance from 
the brain and gut of horses, which caused hypotension (V. Euler & Gaddum, 1931). In the spinal cord, 
SP is found in abundance in terminals of primary afferent nerves in the dorsal horn, and in the dorsal 
roots of the spinal nerves. In the dorsal horn, high concentrations of substance P are present in the 
synaptic vesicles of primary afferent nerve fibres (Cuello et al., 1977). Due to the size and hydrophilic 
nature of SP, it crosses the biological membranes poorly, and its release requires the process of 
exocytosis (Persson et al., 1995). SP and CGRP are co-expressed in the peptidergic neurons. 
The release of SP has already been described in chapter 1.4.5.1.  
1.4.5.4 NK1 Receptor 
The tachykinin peptide family certainly represents one of the largest peptide families described in the 
animal organism. SP may be considered as a prototype of the tachykinins. The tachykinins differ in 
their receptor affinity. Substance P binds preferentially to the neurokinin 1 (NK1) receptor. NK1 
receptors are found both in central nervous tissue (mainly in the striatum and in the spinal cord) and in 
peripheral organs. The NK1 receptor is the major mediator of plasma protein extravasation produced 
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by both exogenous and endogenous tachykinins (Abelli et al., 1991; Xu et al., 1992). SP induces 
clathrin-dependent internalization of the NK1 receptor. The complex formed by SP and it receptor 
dissociates in acidified endosomes. SP is degraded and the NK1 receptor is recycled to the cell surface 
(Grady et al., 1995). After binding to its NK1 receptor, substance P modifies Ca
2+
 and K
+
 currents at 
the cellular level (Snijdelaar et al., 2000). 
1.4.5.5 Role of CGRP and SP in the CNS 
CGRP participates in mechanisms of central sensitization that contribute to the development and 
maintenance of chronic pain. In the spinal cord, CGRP increases responses of dorsal horn neurons by 
increasing synaptic transmission and neuronal excitability (Seybold, 2009). In the brain, 
periaqueductal grey (PAG) is an important relay in the descending pathway of analgesia from brain to 
dorsal horn of the spinal cord. CGRP, as well as it receptor, is present in the nerve fibers in PAG. The 
CGRP receptor is involved in the CGRP-induced antinociception in PAG. Other regions of the brain, 
which are known to play important roles in pain modulation, like the nucleus raphe magnus, the 
nucleus accumbens and the central nucleus of amygdala also demonstrate an antinociceptive effect of 
CGRP. CGRP and its receptor are also involved in learning, memory, opioid tolerance and addiction 
(Yu et al., 2009). As CGRP is released from activated trigeminal sensory nerves, dilates intracranial 
and extracranial blood vessels and centrally modulates vascular nociception, CGRP plays an important 
role in the pathophysiology of migraine (Villalon & Olesen, 2009). 
SP and the NK1 receptor have been found within brain areas known to be involved in the regulation of 
stress and anxiety responses. Emotional stressors increase SP efflux in specific limbic structures such 
as amygdala. Depending on the brain area, an increase in intracerebral SP concentration produces 
mainly anxiogenic-like responses in various behavioural tasks (Ebner & Singewald, 2006). 
1.4.5.6 Role of CGRP and SP in the PNS 
Neurogenic inflammation increases vasodilatation, capillary permeability, and activation of 
inflammatory cells. It results from the antidromic (toward the periphery) release of CGRP, substance 
P, and neurokinin A (NKA) from C-afferent terminals of primary sensory neurons distributed to 
almost all the tissues and organs, particularly around the blood vessels. Pharmacological evidence 
shows that CGRP is the primary neuropeptide responsible for neurogenic vasodilation (Benemei et al., 
2009). CGRP causes endothelium and nitric oxide (NO) independent vasodilation through a direct 
action on the smooth muscle cells mediated both by cAMP and activation of ATP-dependent K
+
 
channels. PKA can also directly activate endothelial production of NO, which contributes to CGRP-
triggered vasodilation (Brain & Grant, 2004; Benarroch, 2011). The vascular reaction most clearly 
related to SP release via stimulation of NK1 receptors is an increase in postcapillary venular 
permeability leading to extravasation of plasma proteins. It has been observed that exogenous SP 
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increases vascular permeability in the same regions of the body where plasma protein extravasation is 
elicited by capsaicin (Lembeck & Holzer, 1979). 
 
1.5 Aims of the Thesis 
During my thesis, I have mainly worked on the two following projects:  
1.5.1 Role of ASICs in neuropeptide secretion 
We hypothesized that some neurons expressing ASIC current types 1 and 3 may mediate neuropeptide 
secretion in DRG neurons. This hypothesis was formulated from the discovery that most of the 
neurons expressing ASIC current type 1 were also IB4 negative, in other words, were expressing 
neuropeptides (Poirot et al., 2006). The aim of the study was to determine whether the activation by 
extracellular acidification of ASICs in DRG neurons induces the release of neuropeptides CGRP and 
SP, and to determine the implication of other relevant ion channels in this process. To test this 
hypothesis, we have measured the co-expression of ASICs with CGRP and SP with 
immunocytochemistry and in-situ hybridization. We have also measured with calcium imaging the 
Ca
2+
 entry in DRG neurons due to ASIC activation. We have finally measured the CGRP secretion 
from DRG neurons after an extracellular acidification. 
1.5.2 Role of ASICs in neuropathic pain 
We hypothesized that ASICs could have a role in neuropathic pain. This hypothesis was formulated 
from the observation that in a model of neuropathic pain performed on rat, the relative expressions of 
the different ASICs subunits in DRG neurons were modified by the nerve injury (Poirot et al., 2006). 
To test this hypothesis, we decided to perform the same model on three different mouse strains 
deficient of ASIC1a, -2 or -3. The mechanical hyperalgesia induced by the nerve injury in the left 
hindpaw of the mice was assessed with Von Frey filaments.  
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2. Materials and methods 
2.1 DRG neuron isolation and culture 
Rats were killed using CO2. Lumbar DRGs (L1–L8) were removed bilaterally and collected in PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) containing 50 U ml
−1
 
penicillin and 50 μg ml−1 streptomycin (Invitrogen, Basel, Switzerland). DRGs were then incubated for 
120 min at 37°C in 2 ml Neurobasal A medium (Invitrogen) completed with 10% heat-inactivated 
fetal calf serum (FCS) (Invitrogen), and 22 mM glucose (named here NeuroA medium) to which 
collagenase type P (Roche, Basel, Switzerland) was added to a final concentration of 0.125%. 
Osmolarity was adjusted to 320 mosmol l
−1
 with sucrose. Then, DRGs were washed two times with 
PBS, treated with trypsin 0.25% (Invitrogen) for 30 min at 37°C, washed with NeuroA and taken up in 
2 ml NeuroA, complemented with 50 μg ml−1 DNase and soybean trypsin inhibitor (Sigma, Buchs, 
Switzerland). The ganglia were triturated 4–6 times with a fire-polished Pasteur pipette or a blue tip to 
obtain the cell suspension. DRG neurones were plated either on glass coverslips (12 mm diameter for 
labelling, 22 mm x 40 mm for the calcium imaging), or in 24-wells plate (for the secretion assay), 
previously coated with a high molecular weight (>300’000 Da) poly-l-lysine (Sigma) solution (0.2 mg 
ml
−1
). The neurones were maintained in NeuroA at 37°C, 5% CO2 and 90% humidity for 3 h. Next, 
neurones were maintained at 4°C in Leibovitz's L15 medium supplemented with 10% FCS and 5 mM 
Hepes. Osmolarity and pH were adjusted, respectively, to 320 mosmol l
−1
 using sucrose and pH 7.4 
using NaOH. 
2.2 Immunocytochemistry 
Cells on coverslips were washed three times for five minutes with PBS. Then they were fixed with 
freshly prepared 4% paraformaldehyde in PBS for 20 minutes. Cells were then washed three times in 
PBS containing 0.5% BSA (protease free, Acros Organics). The cells were permeabilized with 0.4% 
Triton X-100 (Sigma) in PBS for 10 minutes. Subsequently, cells were incubated with the first 
antibody or antibodies (if they are raised in different species) in PBS containing 2% BSA, 0.1% Triton 
X-100, for two hours at RT. Cells were washed three times in PBS containing 0.5% BSA. The cells 
were then incubated with secondary antibodies, directed against the primary antibody used before, in 
PBS with 2% BSA, 0.1% Triton X-100, one hour at RT. Cells were washed three times in PBS with 
0.5% BSA. The coverslips were finally mounted on a glass microscope slide with a drop of 
Vectashield medium (Reactolab, Servion, Switzerland). 
When two primary antibodies were used that had been raised in the same species (here rabbit), the 
protocol was modified in the following way. During the first antibody incubation step, only one rabbit 
antibody was used. A Fab fragment secondary antibody against the first primary antibody was then 
  
30 
 
used. A second step of primary and secondary antibody incubation was then performed, using the 
second primary and secondary antibodies, as shown in Figure 8.  
Cross reactions between the second secondary antibody and the first primary antibody were blocked 
with the Fab fragment secondary antibody. The role of this fragment was to block the epitopes of the 
primary antibody to avoid any interference with the secondary antibody of the second step. The 
monovalent nature of Fab fragments furthermore avoided an interaction with the primary antibody of 
the second step (Negoescu et al., 1994).  
In order to block all the epitopes of the first antibody of the first step, a saturating concentration of Fab 
fragments was reached by adding unconjugated Fab fragments (twice the concentration of the 
conjugated fragment) to the Fab fragments conjugated with a fluorescence probe after the incubation 
with the conjugated Fab fragments (Dou et al., 2004).  
 
A B C  
Figure 8: Use of Fab fragments for labelling and blocking 
A: Incubation with the first primary antibody, in this example rabbit anti-antigen X ( ). B: Incubation with excess Fab 
fragments antibody against the host species of the primary antibody, in this example Cy3( )-Fab fragment goat anti-rabbit 
IgG (H+L)( ). C: Incubation with the second primary antibody, rabbit anti-antigen Y ( ), followed by conjugated 
divalent secondary antibody, in this example FITC( )-goat anti-rabbit IgG (H+L)( ). To simplify the scheme, only the 
conjugated Fab fragments were depicted, avoiding the unconjugated Fab fragments. Adapted from: 
http://www.jireurope.com/technical/examplea.asp 
2.2.1 Test of ASIC2 antibody 
The ASIC2 antibody was a generous gift from Heather A. Drummond (Gannon et al., 2008b). It was 
tested here for its specificity on mouse DRG neurons. Figure 9 shows that the antibody is specific, as it 
stained the DRG from wild type mice, but not from ASIC2 knock-out mice. 
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Figure 9: Test of ASIC2 antibody on ASIC2 knock-out DRG 
The antibody dilution was 1/200. Scale bar: 200 µm 
2.3 In-situ hybridization 
For the in-situ hybridization the general protocol described by Zaal Kokaia was followed (Kokaia, 
2001). 
2.3.1 Preparation of cells 
The cells were rinsed twice in PBS, two min each, at RT. Then the cells were fixed in 4% 
paraformaldehyde solution for 10 min at RT. The cells were again rinsed twice in PBS, for two min 
each, at RT. They were permabilized in PBS, 0.1% Triton X-100, 5% vanadyl ribonucleoside complex 
(VRC; New England Biolabs, Ipswich, USA) for five minutes at RT (Bobrow & Moen, 2001). 
2.3.2 Labelling of oligonucleotides 
The oligonucleotides were labelled with digoxigenin-ddUTP with the DIG Oligonucleotide 3’-End 
Labelling Kit (Roche), following the manufacturer’s protocol. Briefly, 100 pmol oligonucleotide were 
added to a reaction vial, along with sterile double distilled water to make a final volume of 10 µl. Then 
4 µl reaction buffer 5x, 4 µl CoCl2 solution, 1 µl DIG-ddUTP solution and 1µl terminal transferase 
were added to the vial. The content of the vial was then mixed, centrifuged briefly and incubated at 37 
°C for 15 min, then put on ice. The reaction was stopped by adding 2 µl 0.2 M EDTA (pH 8.0). The 
final concentration of the oligonucleotides was 2.5 pmol/μl. The labelling efficiency was then 
estimated via a direct detection method. A series of dilutions of DIG-labeled oligonucleotide was 
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bound to a small strip of positively charged membrane (Amersham Hybond-ECL nitrocellulose 
membrane, GE Healthcare, Glattbrugg, Switzerland). A part of the membrane was preloaded with 
known concentrations of provided DIG-labelled control oligonucleotide. The oligonucleotides were 
cross-linked on the membrane with UV light. The labelled nucleotides on the membrane were detected 
with an anti-DIG-alkaline phosphatase (AP)-labelled antibody (1:500, Roche) and an AP substrate 
(BCIP/NBT Liquid Substrate System, Sigma). The intensity of the dots was compared between the 
labelled nucleotides and the controls to evaluate the efficiency of the labelling. The dots were still 
visible at 1-3 fmol/μl dilutions. As there were no significant differences between the different labelled 
oligonucleotides and the labelled control oligonucleotide, all the nucleotides were considered as 
labelled. 
2.3.3 Hybridization and detection of the oligonucleotides 
2 µl (5 pmol) of DIG-labeled probe was added to 1 ml of hybridization buffer (see section 2.3.4) to 
form the hybridization mix. Hybridization mix was applied on the cells on coated coverslips (high 
molecular weight poly-l-lysine (Sigma)). The cells were incubated in a humidified chamber sealed 
with tape and placed in a 37°C incubator for 16 to 18 hours. The coverslips were then rinsed quickly in 
dishes with 1x SSC (see section 2.3.4), at 48°C to remove the hybridization mix. The dishes were 
filled with 1X SSC, preheated to 48°C, on top of a water bath at 48°C.  The 1X SSC solution was 
changed three times, once every 30 minutes. For the last wash, 1X SCC at 48°C was added, then the 
dishes were removed from the water bath and allowed to cool to room temperature. The coverslips 
were washed twice, each time for five minutes in binding buffer (see section 2.3.4) at RT. The 
coverslips were incubated in binding buffer containing either the anti-DIG-alkaline phosphatase-
conjugated antibody (1:500, Roche), or the anti-DIG-fluorescein-conjugated antibody (1:10, Roche), 
1% normal sheep serum (Invitrogen) and 0.3% Triton X-100 (Sigma) for three hours in a humidified 
chamber at RT. When the incubation was completed, the coverslips were briefly rinsed in binding 
buffer. Then, the slides were washed three times, each time for 10 min, in binding buffer at room 
temperature. The coverlips were rinced briefly in wash buffer (see section 2.3.4) and washed for five 
minutes in wash buffer. For the alkaline phosphatase conjugated antibody, an AP substrate 
(BCIP/NBT Liquid Substrate System, Sigma) producing a blue-purple precipitate was applied for 12 
to 24 hours in the dark at RT. The reaction was stopped by washing the slides twice, each time for five 
minutes in stop buffer (see section 2.3.4). Finally, with both alkaline phosphatase- or fluorescein-
conjugated antibodies, coverslips were washed twice for five min with water at room temperature and 
were mounted with a drop of Vectashield medium (Reactolab). 
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2.3.4 Solutions 
All the solutions of this section were prepared with DEPC-treated water (250 μl/l (v/v) DEPC), 
autoclaved. 
Hybridization buffer (50% (v/v) deionized formamide (Sigma), 4× SSC, 1× Denhardt solution, 1% 
sarkosyl, 10 ml 30 mM phosphate buffer, pH 7.0,  0.55 mg/ml (v/v) salmon testes DNA (Sigma), 100 
g/l (w/v) dextran sulphate (Sigma)) 
SSC, 20×, pH 7.0 (3 M NaCl, 300 mM sodium citrate dihydrate (C6H5Na3O7×2H2O)) The pH was 
adjusted to pH7.0 with NaOH or concentrated HCl.  
Denhardt solution, 50× (10 g/l polyvinylpyrrolidone (Sigma), 10 g/l BSA (proteases free, Acros 
Organics), 10 g/l Ficoll (Sigma)) 
Sarkosyl, 20% (w/v) (200 g/l (w/v) N-laurylsarcosine (Sigma)) 
Phosphate buffer, 0.2 M (50 mM NaH2 PO4 × H2O, 150 mM Na2 HPO4) 
Binding buffer (150 mM NaCl, 100 mM Tris) The pH was adjusted pH 7.5 with HCl. 
Wash buffer (100 mM NaCl, 100 mM Tris, 50 mM MgCl2×6H2O) The pH was adjust to pH 9.5 with 
HCl. 
Stop buffer (150 mM NaCl, 10 mM Tris, 1 mM EDTA) The pH was adjust to pH 7.5 with HCl. 
2.3.5  Oligonucleotides sequences 
The oligonucleotides were selected to match the sequence (sense probe) or the complementary 
sequence (antisense probe) of the cDNA of the different ASIC subunits. The following parameters 
were used to select the oligonucleotides. The desired GC content had to be between 48 and 62%.  The 
oligonucleotide length had to be between 42 and 54 nucleotides. The calculated melting point of the 
oligonucleotide had to be between 100°C and 106°C. The oligonucleotide had not to contain hairpins 
with free energy more negative than -4.7 kcal. Finally, the sequence of the oligonucleotide had to 
avoid runs of more than five identical nucleotides in series (Erdtmann-Vourliotis et al., 1999).  
The designed oligonucleotides were tested as described in section 2.3.6. When the negative control 
experiments were not negative, the oligonucleotide was redone. 
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 sense probes 
ASIC1a 5'-GATGAAAAGCAGCTAGAGATATTGCAGGACAAGGCCAACTTCCGGAGCTTC-3' 
ASIC1b 5'-AGAGGAAGAGAAGGAAATGGAGGCAGGGTCGGAGTTGGATGAGGGTGATGA-3' 
ASIC2a 5'-CATCAGCGCTGCCTTCATGGACCGTTTGGGCCACCAGCTGGAGGATATGCT-3' 
ASIC2b 5'-CAGCCTGCAACCTTCCAGTATCCAGATCTTCGCCAATACCTCCACTCTCCA-3' 
ASIC3 5'-GCTGTGCTCCTGTCGCTGGCGGCCTTCCTCTACCAGGTGGCTGAGCGG-3' 
Table 1 : List of ASIC subunits sense oligonucleotides 
 
 antisense probes 
ASIC1a 5'-GAAGCTCCGGAAGTTGGCCTTGTCCTGCAATATCTCTAGCTGCTTTTCATC-3' 
ASIC1b 5'-TCATCACCCTCATCCAACTCCGACCCTGCCTCCATTTCCTTCTCTTCCTCT-3' 
ASIC2a 5'-AGCATATCCTCCAGCTGGTGGCCCAAACGGTCCATGAAGGCAGCGCTGATG-3' 
ASIC2b 5'-TGGAGAGTGGAGGTATTGGCGAAGATCTGGATACTGGAAGGTTGCAGGCTG-3' 
ASIC3 5'-CCGCTCAGCCACCTGGTAGAGGAAGGCCGCCAGCGACAGGAGCACAGC-3' 
Table 2 : List of ASIC subunits anti-sense oligonucleotides 
 
2.3.6 Test of  in-situ hybridization probes against ASIC subunits 
The probes against ASIC1a, -1b, -2a, -2b, and 3 mRNA were tested on CHO cells expressing stably or 
transiently one of the five ASIC subunits. ASIC1a, -1b and -2a were stably expressed in CHO cells, 
ASIC2b and -3 were transiently co-expressed with eGFP (the eGFP staining is shown in the images 
showing green fluorescence) (Figure 10).  
For each subunit, a specific antisense probe was designed, as well as the complementary sense probe 
as a negative control. As a supplementary negative control, each antisense probe was also tested on 
CHO cells either expressing no ASICs or another ASIC. Figure 10 shows that the antisense probes are 
specific. On the left panels, representing the specific staining of each probe for the corresponding 
ASIC subunit, cells were dark stained with BCIP/NBT precipitate. This dark precipitate indicated that 
the probes recognised the mRNA of the corresponding subunits. In the middle panels, the sense probes 
were used as negative controls. On most cells, there was no, or background staining, showing that the 
sense probes did not recognise ASIC mRNAs. On the right panels, the antisense probes were used on 
CHO cells that were not expressing the corresponding ASIC subunit. These negative controls had no 
or basal staining, meaning that the probes seemed to be specific to their corresponding ASIC subunit. 
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Figure 10 : Test of in-situ hybridization probes (antisense and sense) for ASIC1a, -1b, -2a, -2b and -3 in CHO cells. 
Scale bar: 100 µm. 
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2.4 Microscopy and cell counting 
Both immunocytochemistry and/or in-situ hybridization experiments slides were imaged using a 
confocal microscope (LSM 710, Zeiss, Feldbach, Switzerland), with an EC Plan-Neofluar 40x/1.30 
Oil DIC M27 objective. The confocal microscope was operated with the LSM Software ZEN 2009 
(Zeiss). The “smart setup” tool was used to select the appropriate dyes and the “Fastest” acquisition 
mode was selected. For counting purposes, large images were taken by using “tile scan”. The large 
image was done by imaging seven x seven 512 x 512 pixels images at a resolution of 0.45 µm / pixel, 
resulting in a 3584 by 3584 pixels image. The confocal “.lsm” images files were converted to “.jpg” 
files with Axiovision LE (Zeiss). To count the positive cells for a given fluorescent dye, the ImageJ 
software was used. Briefly, the grey scale images for each fluorescent dye were opened in the 
software. For each experiment, a mouse primary monoclonal antibody against NeuN, a neuronal 
marker, followed by an anti-mouse cy5 secondary antibody was used to stain all neurons. The cy5 
image was used to create regions of interest (ROI). Each region delimited a neuron. The average grey 
scale value was then measured for each region of interest for each fluorophore (except for the cy5). 
For each set of experiment and each type of antibody or oligonucleotide, a threshold value was then 
chosen, above which a neuron was counted as positive. 
2.5 Calcium imaging 
The cells were plated on large 22 mm x 40 mm coverslips coated with high molecular weight poly-l-
lysine (Sigma) solution (0.2 mg ml
−1
). Cells were washed with 1x PBS. Coverslips were mounted in 
the perfusion chamber (Warner Instruments, Hamden, USA), using grease to seal the coverslip to the 
bottom of the chamber. For CHO cells, cells were incubated with 5 µM Fura2-AM in 1ml of pH 7.4 
Tyrode solution directly in the perfusion chamber for 30 min in the dark in a 37°C water bath. For 
neurons, the time of incubation was reduced to 20 minutes. After incubations, cells were perfused for a 
few minutes with pH 7.4 Tyrode to rinse the Fura2-AM. Up to eight different solutions were perfused 
on the cells with the Solution Changer Manifold MSC-200 (Bio-Logic, Claix, France). The solutions 
were exchanged with a CFlow flux controller (Cell MicroControls, Norfolk, USA). The imaging 
solution was the VisiFluor system (Visitron Systems, Puchhein, Germany) with a CoolSnap HQ 
camera, VisiChrome polychromator and Metafluor software (Molecular Devices, Sunnyvale, USA). 
Briefly, for each time point, two images were taken at excitation wavelengths of 340 and 380 nm. The 
emitted fluorescence at 520 nm was recorded trough an emission filter. A ROI was drawn on images 
to select regions which correspond to cells. The average grey scale level for each ROI was calculated 
for each 340 and 380 nm image at each time point. A region empty of cells was also selected to have a 
measure of the background fluorescence. The background values for each time point at 340 and 380 
nm wavelengths were subtracted for each value. The ratio between the fluorescence at 340 nm and 380 
nm (340/380) was then plotted as a function of the time. 
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2.6 In vitro CGRP secretion assay with DRG neurons 
Freshly dissociated neurons were plated into 24 well dishes, coated with a high molecular weight poly-
l-lysine (Sigma) solution (0.2 mg ml
−1
). Neurones were maintained during ~18 hours in NeuroA at 
37°C and 5% CO2. The cells were then first washed one time with PBS, then a second time with PBS 
containing protease inhibitors (Leupeptin (1μg/ml), Pepstatin (1μg/ml), Aprotinin(1μg/ml), PMSF (1 
mM) (Roche, Rotkreuz, Switzerland)) and 0.3 % bovine serum albumin (BSA) (proteases free, Acros 
Organics part of Fisher Scientific, Wohlen, Switzerland). Protease inhibitors and 0.3 % BSA were 
added to all the solutions used in this this assay. In this assay, secretion was measured during a 20 min 
period. For some pharmacological compounds a preincubation was necessary. In these cases, the 
compounds were incubated for 5 min at room temperature (RT) in 200 µl Tyrode (140 mM NaCl, 4 
mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM MES, 10 mM Hepes, 10 mM glucose) at pH 7.4. The 
corresponding negative controls were preincubated with 200 µl Tyrode at pH 7.4. The preincubation 
solutions were then removed. Subsequently, 200 µl Tyrode solution adjusted to the desired pH with or 
without pharmacological compounds were added to each well. The wells were incubated for 20 min on 
top of a water bath at 37°C. After the incubation, the supernatant of each well was transferred into a 
polyethylene tube (Nunc-Immuno™ Tubes MiniSorp, Fisher Scientific, Wohlen, Switzerland) and 
kept on ice. Tubes were centrifuged for 10 min at 500 rpm at 4°C. The supernatants were transferred 
into new polyethylene tubes and then frozen at -80 °C. In each well, the cells were incubated for 5 min 
with 100 μl lysis buffer (50 mM Tris pH7.5, 5 mM EDTA, 1% Triton X-100), then harvested. The 
lysates were then transferred to polyethylene tubes, sonicated a few seconds at 4°C and then frozen at -
80 °C. They were used to determine the cellular content in CGRP in order to normalize the secretion 
of each well. The CGRP content of the supernatants and the lysates were subsequently measured using 
an enzyme immunoassay kit, as described in the next section. 
2.7 CGRP enzyme immunoassay 
CGRP content of the supernatants and the lysates samples were measured using a rat CGRP enzyme 
immunoassay (EIA) kit (SPI-bio, Montigny le Bretonneux, France). This kit was used according to the 
manufacturer’s recommendations. Briefly, the lyophilised CGRP of the standard vial was reconstituted 
with 1 ml of experimental solution (Tyrode solution adjusted to pH 7.4, supplemented with 0.3% 
BSA, protease inhibitors). A serial dilution of the standard was performed to obtain the following 
concentrations: 500 (S1), 250 (S2), 125 (S3), 62.5 (S4), 31.25 (S5), 15.6 (S6), 7.81 (S7), 3.91 pg ml
-1
. 
The lyophilised CGRP of the quality control vial was reconstituted with 1 ml of the experimental 
solution. The lysates were diluted fifty times with experimental solution, to ensure that the measured 
CGRP concentration was in the detection range of the kit. Wells of the 96 well plate, precoated with a 
CGRP mouse monoclonal antibody, were washed five times with the provided wash buffer. 100 µl of 
sample (supernatant or diluted lysate), quality control or standard solution were pipetted into each 
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well. Each measurement was performed in duplicate. The blank (B) wells were kept empty and 100 µl 
of experimental solution were pipetted into the non-specific binding (NSB) wells. The plate was then 
covered with a plastic film and incubated 16 to 20 hours at 4°C without shaking. The anti-CGRP-
AChE tracer was then reconstituted with 10 ml of the provided EIA buffer. 100 µl of the tracer was 
pipetted into each well, except the blank wells and briefly mixed. The plate was again covered with a 
plastic film and incubated 16 to 20 hours at 4°C. The plate was then emptied by turning over and 
shaking. Each well was washed three times with the wash buffer (300 µl per well), slightly shaken for 
2 minutes with an orbital shaker and then rewashed three times with the wash buffer. A few minutes 
before use, the Ellman’s reagent was reconstituted with 49 ml of deionized water and 1 ml of 
concentrated wash buffer. 200 µl of Ellman’s reagent was added to each well. The plate was incubated 
in the dark, covered with an aluminium sheet at room temperature. The plate was read with a 
spectrophotometer plate reader at 405 nm between 30 to 60 minutes after adding the Ellman’s reagent. 
To analyse the data, first of all, the average of the blank wells was substracted from the absorbance 
reading of the rest of the plate. The average absorbance for each NSB, standard and sample well was 
calculated. The absorbance for each standard versus the concentration was plotted. The concentration 
for each sample was determined using the equation of the fit of the standard curve. 
2.8 Animal surgery 
All experiments were approved by the Committee on Animal Experimentation of the Canton de Vaud, 
Switzerland, in accordance with Swiss Federal law on animal care and the guidelines of the 
International Association for the Study of Pain (IASP) (Zimmermann, 1983). 8-10 week-old C57BL/6 
male mice were housed in the same room, one per cage, at constant temperature (21 ± 2 °C) and a 
12/12 dark/light cycle. No other animals were housed in that room. Mice had ad libitum access to 
water and food. 
The spared nerve injury (SNI) model consists of sparing the sural nerve, while two other terminal 
branches of the sciatic nerve are injured (common peroneal and tibial nerves). Intense, reproducible 
and long-lasting mechanical allodynia-like behaviour is measurable in the non-injured sural nerve skin 
territory (Decosterd et al., 2004). The surgery was performed as previously described (Bourquin et al., 
2006). SNI surgery was performed under general anaesthesia by 1.5–2.5% isoflurane. The left 
hindlimb was immobilized in a lateral position and slightly elevated. Incision was made at mid-thigh 
level using the femur as a landmark and a section was made through the biceps femoris in the direction 
of point of origin of the vascular structure. At that stage, the surgery continued with the help of a 
stereomicroscope. The three peripheral branches (sural, common peroneal, and tibial nerves) of the 
sciatic nerve were exposed without stretching nerve structures. Both tibial and common peroneal 
nerves were ligated and transected together. A micro-surgical forceps with curved tips was delicately 
placed below the tibial and common peroneal nerves to slide the thread (6.0 silk) around the nerves. A 
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tight ligation of both nerves was performed and a 1–2 mm section of the two nerves was removed. The 
sural nerve was carefully preserved by avoiding any nerve stretch or nerve contact with surgical tools. 
Muscle and skin were closed in two distinct layers with silk 6.0 sutures.  
2.9 Behaviour 
The following behavioural experiments, as well as the previously described SNI model surgery, were 
performed in collaboration with the group of Isabelle Decosterd. The surgery was performed by 
technicians of Isabelle Decosterd’s group (Marie Pertin, Guylène Magnin). I learned the behavioural 
experiments procedures with Marie Pertin for the Von Frey experiments and with Guylène Magnin for 
the hot plate and tail-flick experiments. 
2.9.1 Von Frey monofilaments 
Testing procedures started with one week of acclimatization of the animals to the testing room 
environment, with handling reduced to a minimum. For another week, mice were habituated to the 
testing material. The experimenter placed each mouse on an elevated platform with a 20 mm soft wire 
mesh floor, in a transparent Plexiglas box (10 × 10 × 13 cm) for a 15-min session every two days. 
During the last session, mice were familiarized with the application of von Frey monofilaments under 
the paw. Recordings of mechanical sensitivity were then performed before and after surgery. Two sets 
of baseline measurements were taken, baseline 1 at 4 days before surgery and baseline 2 at 2 days 
before surgery. Measurements were also taken 3, 9, 15 and 21 days after SNI. The investigator was 
blinded to the genotype of the mice. The plantar side of the hindpaw ipsilateral or contralateral to the 
surgery was stimulated with calibrated von Frey monofilaments (Stoelting Co, Wood Dale, USA). 
Monofilaments were applied perpendicularly to the glabrous skin with sufficient force to cause 
filament bending. Ten stimuli were made with each of a series of Von Frey hairs comprised of the first 
11 monofilaments supplied by the manufacturer (0.008, 0.02, 0.04, 0.070, 0.16, 0.40, 0.60, 1.0, 1.4, 
2.0, and 4.0 g). We measured the number of positive withdrawal responses in ten applications for each 
monofilament of the series. The 11 monofilaments were tested in ascending order to determine the 
relative frequency of paw withdrawal. The number of hindpaw withdrawal after 10 stimulations is a 
measure of the sensitivity of the animal to the stimulations. Classically, with wild type mice, the 
number of withdrawal of the ipsilateral hindpaw increases after the SNI surgery, for a given filament. 
On the contrary, the number of withdrawal of the contralateral hindpaw does not change after SNI 
surgery.  
2.9.2 Hot plate 
Mice were habituated to the testing material for four days before the measurements. Mice were placed 
in a transparent acrylic box without bottom which was placed on a cold and hot plate analgesia meter 
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(Bioseb, Paris, France) maintained at 49, 52, or 55°C. The reaction time was scored when the animal 
licked its paws or jumped. The maximal time of exposure was set to 40 s to avoid any paw damage. 
Three measurements for each mouse were taken and averaged for a single temperature each day, 
leaving a couple minutes between each measurement. The three different temperatures were assessed 
on three different days, first 49, then 52 and finally 55°C.  
2.9.3 Tail flick 
Mice were habituated to the testing material the day before the experiment. The tail flick procedure 
was carried out as previously described (Dewey et al., 1970). Mice were immobilized in a cone shape 
tissue, leaving the tail out of the tissue. The tail was then placed on the light beam path of the Tail-
Flick Analgesia Meter (Columbus Instruments, Columbus, USA). In order to avoid tissue damage, a 
maximum latency of 10 s was imposed. The intensity of the light falling on the tail of the mouse was 
adjusted such that each reaction time fell within the 10 s range. This intensity was then maintained for 
the entire experiment. Three measurements, taken 30 minutes apart, were averaged and constituted the 
time of reaction.  
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3. Results 
3.1 Distribution of ASICs, TRPV1 and neuropeptides in rat DRG neurons 
We have analysed the distribution of ASICs, TRPV1 and neuropeptides (CGRP and SP) in the rat 
DRG neurons in culture, more specifically the coexpression of the different ASIC subunits with the 
neuropeptides, and also the coexpression of different ASIC subunits. In order to test for these 
coexpressions, two different approaches were used. First, immunocytochemistry was performed on the 
cells for ASIC1 (antibody recognising both ASIC1a and ASIC1b subunits), ASIC2 (antibody 
recognising both ASIC2a and ASIC2b subunits), TRPV1, CGRP and SP. To distinguish between the 
different isoforms of ASIC1 and ASIC2, and to show the distribution of ASIC3, in-situ hybridization 
was used. 
3.1.1 ASIC1, -2 and TRPV1 are preferentially localised in peptidergic neurons   
Immunocytochemistry was performed on dissociated rat DRG neurons. In each immunostaining 
experiment, the neurons were also stained for NeuN, a neuronal marker, to mark each neuron and 
distinguish them from non-neuronal cells in the preparation. Double staining experiments were carried 
out (see Methods). Each neuron was then assigned as positive or negative for the expression of 
neuropeptides (CGRP or SP, red, in Figure 11), or ASICs/TRPV1 (green). The different 
subpopulations were then counted and represented in concentric pie charts. Figure 11 shows in panels 
A and B the immunostaining and the proportion of subpopulations of neurons expressing respectively 
CGRP or SP and ASIC1. Panel C shows the proportion of subpopulations of neurons expressing 
respectively CGRP or SP and ASIC2; panel D the proportion of subpopulations of neurons expressing 
respectively CGRP or SP and TRPV1. All DRG neurons, not only small diameter neurons, were 
included in the experiments shown in this figure.  
On average CGRP and SP were found to be present in about half of the neurons. ASIC1 and CGRP are 
co-expressed in 45% of the neurons, whereas ASIC1 and SP are co-expressed in 39% of the neurons. 
The staining thus showed that ASIC1a and/or ASIC1b (the antibody labels both isoforms) are 
preferentially co-expressed with neuropeptides. ASIC2 and CGRP are co-expressed in 57% of the 
neurons and ASIC2 and SP are co-expressed in 41% of the neurons. Therefore ASIC2a and/or ASIC2b 
(the antibody labels both isoforms) are preferentially co-expressed with neuropeptides. TRPV1 and 
CGRP are co-expressed in 46% of the neurons and TRPV1 and SP are co-expressed in 39% of the 
neurons. It showed that TRPV1 are preferentially co-expressed with neuropeptides. 
No subtype specific antibodies for ASIC1a/b or ASIC2a/b are available and all ASIC3 antibodies 
tested are not good enough for immunocytochemistry in neurons. In order to have a better view on the 
expression of the five different ASIC subunits, we decided to carry out in-situ hybridization 
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experiments to have a better understanding of the expression of ASIC subunits in the peptidergic and 
non-peptidergic population of nociceptors. 
 
Figure 11 : Co-expression of ASIC1, -2, and TRPV1 with neuropeptides in DRG neurons  
Panels A and B show immunostaining for ASIC1, CGRP and SP respectively. The bar is 100 μm. The proportions of 
subpopulations expressing ASIC1 and CGRP or SP are shown in a concentric pie chart on the right. Panel C shows the 
proportions of subpopulations expressing ASIC2 and CGRP or SP. Panel D shows the proportions of subpopulations 
expressing TRPV1 and CGRP or SP. The total number of cells are respectively 661 for ASIC1/CGRP staining, 471 for 
ASIC1/SP staining, 124 for ASIC2/CGRP staining, 311 for ASIC2/SP staining, 58 for TRPV1/CGRP and 75 for TRPV1/SP.  
3.1.2 In situ hybridization experiment confirm that ASIC subunits are preferentially 
expressed in the peptidergic population of small neurons 
As in the previous experiments, anti-NeuN antibodies were used to label the neurons and anti-CGRP 
and anti-SP antibodies were used to detect the neuropeptides CGRP and SP. Prior to this standard 
immunostaining, in-situ hybridization was performed on DRG neurons with the probes previously 
tested, as described in section 2.3.6.  
In Figure 12, only the conditions with antisense probes are shown, as the sense probes showed no or 
very faint staining compared to antisense probes. Confocal images of staining with ASIC1a antisense 
probes are shown (green), along with immunostaining by anti-NeuN (pink) and anti-CGRP (red). 
Figures for the analogous analyses for ASIC1b, -2a, -2b and -3 are shown in Annexes (pp.78-80). 
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Figure 12 : Example of staining of ASIC1a with in-situ hybridization on DRG neurons  
ASIC1a antisense probe, shown in green, and anti CGRP antibody, shown in red are used. Scale bar: 100 µm. In the merged 
image, cells which are positive for NeuN, CGRP and ASIC1a appear yellow. 
In Figure 13, the proportion of subpopulations of neurons expressing for each ASIC mRNA probe and 
neuropeptides CGRP or SP are shown in pie charts. Only the neurons whose apparent diameters were 
smaller or equal to 30 μm were used for this analysis. The diameters of the neurons were estimated 
using the area of the NeuN staining for each cell. The area of the neuron was converted as a diameter, 
by approximating the area of the neuron as a disc.  
ASIC1a mRNA was expressed in about 60% of small diameter DRG neurons. ASIC1a mRNA was co-
expressed with CGRP peptide in 43% of the small diameter neurons and with SP peptide in 49% of the 
small neurons, as seen in the first two charts of the first row in Figure 13. A large part of the neurons 
that expressed ASIC1a also expressed CGRP and SP. The last two charts of the first row show that 
ASIC1b mRNA was less expressed (36-37% of small diameter neurons) than ASIC1a mRNA. Most of 
neurons expressing ASIC1b also expressed CGRP (74%) and SP (91%). Almost all neurons 
expressing ASIC1b were also expressing neuropeptides, but about 44% of CGRP-positive neurons and 
44% of the SP-positive neurons did not express ASIC1b. The first two charts of the second row show 
that about 26-27% of the small diameter neurons expressed ASIC2a. Almost all small neurons 
expressing ASIC2a also expressed CGRP (87%) and SP (100%). About half of the neuropeptide-
positive neurons expressed ASIC2a.  
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Figure 13 : ASIC subunits are preferentially expressed in the peptidergic population of small DRG neurons  
Each pie chart shows the proportion of subpopulation of neurons expressing ASIC1a, 1b, 2a, 2b, 3 and CGRP or SP, 
respectively, on small (< 30 um diameter) DRG neurons. ASIC staining (green) was determined by in situ hybridization and 
neuropeptides staining (CGRP/SP, red) by immunostaining. The total number of cells are respectively 214 for ASIC1a/CGRP 
staining, 133 for ASIC1a/SP staining, 177 for ASIC1b/CGRP staining, 213 for ASIC1b/SP staining, 226 for ASIC2a/CGRP 
staining, 278 for ASIC2a/SP staining, 357 for ASIC2b/CGRP staining, 267 for ASIC2b/SP staining, 334 for ASIC3/CGRP 
staining, 281 for ASIC3/SP staining. 
The last two charts of the second row show that the results for ASIC2b were similar to ASIC2a. About 
32% of the small diameter neurons expressed ASIC2b. Almost all small neurons expressing ASIC2b 
also expressed CGRP (84 %) and SP (97%). About half of the neuropeptide-positive neurons did not 
express ASIC2b. The last row shows results for ASIC3 which are similar to the ASIC1a results. About 
52% of the neurons expressed ASIC3 mRNA. ASIC3 and CGRP were co-expressed in 35% of the 
small diameter neurons, and ASIC3 and SP were co-expressed in 44% of the small diameter neurons.  
To summarize, these results clearly show that all ASICs subunits are preferentially expressed in the 
peptidergic population of small diameter neurons. The most widely distributed ASIC subunits are 
ASIC1a and -3. ASIC1b, -2a, and -2b are expressed in a smaller population of small diameter DRG 
neurons. 
In order to investigate the co-expression of ASICs subunits, immunocytochemistry with either anti- 
ASIC1 or anti-ASIC2 antibodies was performed after the in-situ hybridization. In Figure 14, the top-
left chart shows the co-expression between ASIC1 (ASIC1a and -1b) proteins and the ASIC1a mRNA 
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in small DRG neurons. 39 % of the small neurons were both positive to ASIC1 protein and ASIC1a 
mRNA. Interestingly 16% of ASIC1a mRNA positive neurons were negative to ASIC1 antibody, 
either showing a differential expression between the protein and the mRNA, or a difference of 
sensitivity between the immunostaining and the in-situ hybridization techniques. The left-bottom chart 
shows that 49% of the small neurons expressing ASIC1 proteins also expressed ASIC3 mRNA. Even 
if, as mentioned before, the immuno- and the in-situ hybridization-staining cannot be directly 
compared, it showed that a rather large population of neurons expressed both ASIC1a or -1b together 
with ASIC 3. The right charts showed that ASIC1a and ASIC3 mRNA have only a slight co-
expression with ASIC2 proteins (10% and 18 % respectively). The quantification of ASIC2 
immunostaining was different in this figure compared to Figure 11. This difference was certainly due 
to the fact that in this figure, only the small diameter DRG neurons were taken into account, whereas 
all DRG neurons were taken into account in Figure 11. It means that there was less staining of ASIC2 
in small neurons. This hypothesis is confirmed by evidences that most ASIC2-positive neurons were 
medium-to-large neurons (Kawamata et al., 2006). 
 
Figure 14 : A large population of neurons express both ASIC1a/1b and ASIC 3 
The pie charts show the expression of ASIC1 and 2 proteins (red) with ASIC1a and 3 mRNA (green). The total number of 
cells are respectively 119 for ASIC1a/ASIC1 staining, 149 for ASIC1a/ASIC2 staining, 95 for ASIC3/ASIC1 staining, 85 for 
ASIC3/ASIC2 staining. 
ASIC1a, which can form a Ca
2+
-conducting homomeric channel and ASIC3 were expressed in a large 
proportion of the small peptidergic neurons. Considering their pH50 (see section 1.2.4), activation of 
these ASICs occurs at mildly acidic pH and would mediate an entry of Na
+
 and Ca
2+
 into the 
peptidergic neurons. To investigate the increase of calcium in the DRG neurons, calcium imaging 
experiments were performed. 
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3.2 Functional experiments with calcium imaging on cells in culture 
3.2.1 Heterologous expressed ASIC1a and TRPV1 are activated by extracellular acidification 
In a first series of experiments we tested whether the activation of ASIC1a or TRPV1 increases the 
ratio of intracellular fluorescence, which would indicate an increase of the intracellular calcium 
concentration. Human ASIC1a (hASIC1a) and rat TRPV1 (rTRPV1) were separately stably expressed 
in CHO cells. In Figure 15, panel A, a typical fluorescence trace from a cell expressing ASIC1a is 
shown. A brief (30 s) extracellular acidification to pH 6 increased the intracellular fluorescence.  
N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropryazine-1(2H)-carbox-amide (BCTC) 
is an inhibitor of capsaicin- and acid-mediated currents in rat TRPV1 (Pomonis et al., 2003). 
Co-perfusion of an extracellular solution at pH 6 with increasing concentrations of amiloride (100, 200 
and 500 µM) showed a concentration-dependent reduction of the induced fluorescence. The 
fluorescence amplitude obtained in the presence of amiloride was normalized to the fluorescence 
amplitude of the pH6 condition and plotted in panel B (n = 8). A paired t-test showed that the decrease 
of fluorescence was significative for the condition with 200 and 500 µM amiloride (p-value = 0.020 
and 0.0004, respectively). Amiloride at a concentration of 500 µM reduced the increase in intracellular 
calcium by 87%. This concentration of amiloride was chosen for all the following experiments. The 
estimated IC50 for amiloride in these experiments was 272 ± 40 μM. 
Panels C and D show that an acidification to pH 5 produced an increase of fluorescence in TRPV1-
expressing cells. 500 µM amiloride increased non-significantly the pH 5-induced fluorescence change 
(paired t-test, p-value = 0.103, n= 3). Panels E and F show that 1 µM and 5 µM BCTC decreased the 
fluorescence induced by an extracellular acidification to pH 5 by respectively 72 and 88 % (paired t-
test, p-value = 0.002, n = 4, p-value = 0.009, n = 8, respectively). BCTC showed no significant effect 
on ASIC1a (data not shown).  
We conclude that activation of both ASIC1a and TRPV1 can increase the intracellular calcium 
concentration in cells, that amiloride inhibits ASIC1a, but not TRPV1, and that BCTC inhibits 
TRPV1, but not ASIC1a. The effect of amiloride on TRPV1 was not significant, but as the number of 
n is very low (n = 3), it is possible that increasing the number of experiment could give significant 
differences. It means that amiloride could affect TRPV1 by increasing the conductivity of the channel.  
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Figure 15 : Effect of amiloride and BCTC on ASIC1a and TRPV1 stably expressed in CHO cells 
Panels A and B show the effect of increasing concentrations of amiloride on the amplitude of the pH6-induced fluoresecence 
change in CHO cells expressing ASIC1a, n = 8. Panels C and D show that amiloride had no significant effect on TRPV1, n = 
3. Panels E and F show the inhibition by BCTC of H+-induced intracellular Ca2+ concentration increase in TRPV1 
expressing CHO cells, n = 4 for 1μM BCTC, n = 8 for 5 μM BCTC.*: p-value < 0.05 compared with “pH 6” value, **: p-
value < 0.01 compared with “pH 6” value, ##: p-value < 0.01 compared with “pH 5” value 
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3.2.2 Amiloride prevents the ASIC-induced Ca2+ entry in a population of DRG neurons 
Calcium imaging experiments were performed on dissociated rat DRG neurons. First of all, amiloride 
was used to identify among the neurons responding to extracellular acidification at two pH values (pH 
6 and pH 5), those in which ASICs mediated the Ca
2+
 entry. 
 
Figure 16 : Amiloride inhibits the acid-induced Ca2+ entry in a sub-population of DRG neurons  
Panel A shows a representative trace from an experiment in which amiloride inhibited the increase of fluorescence at pH 5 
and pH 6. Panel B shows a representative trace from an experiment in which amiloride had no effect on fluorescence at pH 5 
and pH 6. These effects are summarized in panel C. n = 4-5 for each group. *: p-value < 0.05 compared with “pH 6” value, 
**: p-value < 0.01 compared with “pH 6” value, #: p-value < 0.05 compared with “pH 5” value, ##: p-value < 0.01 compared 
with “pH 5” value 
In Figure 16, panel A, a representative trace shows that amiloride inhibited the increase in 
fluorescence at pH 5 and pH 6 in a population of cells. As amiloride acts on ASICs, this population of 
DRG neurons expressed mainly ASICs, and did almost not express TRPV1. The kinetics of the 
fluorescence were also compatible with ASICs, as the signal started to decrease still in presence of 
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acidification, reflecting the inactivation of ASICs. This population of neurons in which 500 μM 
amiloride inhibited  ≥ 70% of the pH 5 induced Ca2+ increase was named “Fully amiloride-sensitive”.  
On panel B, a typical trace of a amiloride-insensitive neuron is shown. In contrast to panel A, the 
fluorescence remained high during the extracellular acidification and decreased only when the pH was 
changed back to pH 7.4. In this population of neurons, the increase in intracellular calcium 
concentration was mediated by another channel than ASIC, probably TRPV1. In neurons of this 
population, the pH5-induced increase of intracellular Ca
2+
 concentration was not inhibited (< 0%) by 
500 μM amiloride. These neurons were named “Amiloride-insensitive”. In some cells, amiloride was 
partially effective. This partial effectiveness showed that in these cells, ASICs are only partially 
responsible for the increase of intracellular calcium concentration. In neurons of this population, the 
pH5-induced increase of intracellular Ca
2+
 concentration was inhibited between 50% and 70% by 500 
μM amiloride. These neurons were named “Partially amiloride-sensitive”. We did not find any neuron 
in which the pH5-induced increase of intracellular Ca
2+
 concentration was inhibited by 0% - 50% by 
500 μM amiloride. 
On panel C, the quantification for the three populations is shown. Statistical analysis showed that 
concerning the “fully amiloride-sensitive” population of neurons, amiloride reduced significantly 
fluorescence at pH 5 and 6, compared to their control (paired t-test, p-value = 0.019 and 0.004, 
respectively). For the “Amiloride-insensitive” population of neurons, there was no significant 
differences between the groups (paired t-test, p-value = 0.461 and 0.078 respectively). The “Partially 
amiloride-sensitive” population of neurons, showed a significantly reduced fluorescence with 
amiloride at pH 5 and 6, compared to their control (paired t-test, p-value = 0.042 and 0.013, 
respectively). 
In this experiment, we counted that 31% of the neurons were fully amiloride-sensitive, 38% were 
amiloride-insensitive and 31% were partially amiloride-sensitive (n=13). It means that 62% of the 
neurons were expressing ASICs and that 69 % of the neurons were expressing TRPV1, as we believe 
that the partially amiloride-sensitive neurons express both ASICs and TRPV1. These proportions are 
comparable with the proportions we observed with immunostaining and in-situ hybridization. 
When looking at the traces of the amiloride-sensitive neurons (Figure 16A) and of the amiloride-
insensitive neurons (Figure 16B), it is clearly visible that the acid-induced fluorescence of the 
amiloride-insensitive neurons desensitizes less than the fluorescence of the full amiloride-sensitive 
neurons. To quantify this desensitization, the ratio of fluorescence after 20 sec of stimulation and peak 
fluorescence at pH5 was measured for the full amiloride-sensitive and the amiloride insensitive 
population. The desensitization is measured as the ratio between the fluorescence 20 s after the 
beginning of the pH5 stimultion and the maximum fluorescence during the stimulation. The Figure 17 
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shows that the full amiloride-sensitive neurons mainly expressing desensitize significantly faster than 
and the amiloride insensitive population (unpaired t-test, p-value = 0.003). 
 
Figure 17 : Acid-induced fluorescence of the amiloride-insensitive neurons desensitizes less than the fluorescence of 
the full amiloride-sensitive neurons.  
The ratio of fluorescence after 20 sec of stimulation and peak fluorescence at pH5 was measured for the full amiloride-
sensitive and the amiloride insensitive population. The desensitization is measured as the ratio between the fluorescence 20 s 
after the beginning of the pH5 stimultion and the maximum fluorescence during the stimulation. n = 7 for each group. **: p-
value < 0.01, unpaired t-test 
3.2.3 Psalmotoxin inhibits the activation of ASICs in a population of DRG neurons 
In order to analyse the contribution of homomeric ASIC1a channels to the Ca
2+
 entry, PcTx1 was 
used. As mentioned in section 1.2.6.4, PcTx1 blocks homomeric ASIC1a at nanomolar concentrations. 
In Figure 18, panel A, a representative trace of the PcTx1-sensitive neuron population is shown. 
Amiloride abolished almost completely the response at pH 6, indicating that ASICs were responsible 
for the increase of the intracellular calcium concentration. In the same experiment, 10 nM PcTx1 also 
abolished the response at pH 6. This shows that in this population of neurons, homomeric ASIC1a 
channels were responsible for the increase of the intracellular calcium concentration.  
Panel B shows a representative trace of a neuron whose response to pH6 was also completely 
abolished by amiloride. In this experiment, however, PcTx1 was ineffective inhibiting the response to 
pH 6.  This shows that in this population of neurons, different homomeric or heteromeric ASICs were 
likely responsible for the increase of intracellular calcium concentration. 
Panel C shows a typical trace of a neuronal population in which neither amiloride, nor PcTx1 affected 
the response at pH6, indicating that in these neurons ASICs were not involved in the extracellular 
acid-induced increase of intracellular calcium concentration, as seen in Figure 16, panel C.  
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Figure 18 : PcTx1 inhibits ASIC1a in a population of DRG neurons 
Panel A shows an experiment in which both amiloride and PcTx1 inhibited the increase of fluorescence at pH 6 in a 
representative neuron. Panel B shows an experiment in which PcTx1 had no effect on fluorescence at pH 6 in a representative 
neuron which was sensitive to amiloride. Panel C shows an experiment in which both PcTx1 and amiloride had no effect on 
fluorescence at pH 6 in a representative neuron. These effects are summarized in panel D. n = 5-9 for each group. *: p-value 
< 0.05 compared with “pH 6” value, **: p-value < 0.01 compared with “pH 6” value 
In panel D, the quantification for the three populations is shown. A paired t-test showed that in the 
PcTx1-resistant population, amiloride (p-value = 0.006), and PcTx1 (p-value = 0.016) produced a 
significant decrease of the fluorescence, compared to the values at pH 6. The small (< 30%) decrease 
of fluorescence in the PcTx1 condition was statistically significant. It reflected a mixed population 
with homomeric ASIC1a and other ASICs. In the PcTx1-sensitive population (i.e. >70% of the pH6-
response inhibited by 10 mM PcTx1), both amiloride (p-value = 4.19*10
-5
) and PcTx1 (p-value = 
1.90*10
-4
) produced a significant decrease of the fluorescence, compared to the values at pH 6. In the 
amiloride-resistant population, there were no significant difference between the groups (paired t-test, 
p-value = 0.059 and 0.389). 
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In this experiment, we counted that 64% of the amiloride-sensitive neurons were also PcTx1-sensitive 
(n = 14). This result is comparable with the previous experiments done in our lab showing that the 
type 1 current was present in about half of the total neurons (Poirot et al., 2006). 
3.2.4 Cav inhibitors reduce the amplitude of ASIC-mediated Ca
2+
 increase in DRG neurons 
Calcium can enter the cell via the homomeric ASIC1a in the population of neurons which are sensitive 
to PcTx1. In the amiloride-sensitive, but PcTx1-insensitive DRG neuron population, calcium 
impermeant ASICs are likely involved in the increase of the intracellular calcium concentration 
showing that ASICs mediated indirectly the entry of calcium. We hypothesized that the entry of 
sodium through ASICs could depolarize the plasma membrane and that this depolarization could 
activate Cav. Nifedipine (10 µM), Mibefradil (10 µM) and ω-conotoxin MVIIC (300 nM) were used 
together as pharmacological tools to inhibit a wide range of Cav (see section 1.4.4.2). The three 
inhibitors had been tested in patch-clamp experiments on dissociated DRG neurons. It had been shown 
that these inhibitors at the concentrations mentioned above inhibited the endogenous Cav currents 
(experiments performed by Maxime Blanchard, n=2, data not shown). The combination of these three 
inhibitors is thereafter named as “the Cav inhibitors”.  
In Figure 19, panel A, a typical trace of a neuron sensitive to amiloride is shown. In most of the 
amiloride-sensitive cells, the Cav inhibitors also inhibited a large part of the acid-induced increase of 
intracellular calcium concentration. At the end of the experiment, the effectiveness of the Cav 
inhibitors was assessed with KCl-induced (70 mM) depolarisation. Experiments in which the Cav 
inhibitors were ineffective to block the response to KCl (i.e. inhibition < 60 %) were not taken into 
account for the analysis.  
Panel B shows that the Cav inhibitors were uneffective in blocking the response to an extracellular 
acidification in a population of cells which was insensitive to amiloride.  
In Panels C and D, the quantification of these responses is shown. A paired t-test performed on the 
results of the amiloride-sensitive population showed that both amiloride and Cav inhibitors were able 
to significantly reduce the response to an extracellular acidification at pH 6 (p-value = 0.006 and 0.014 
respectively). For the amiloride-resistant population a paired t-test showed that the Cav inhibitors did 
not significantly prevent Ca
2+
 entry (p-value = 0.322 and 0.384). For both populations, the Cav 
inhibitors prevented the increase of intracellular Ca
2+
 concentration after KCl-induced depolarisation 
(paired t-test, p-value = 0.004 and 0.008 for the amiloride-sensitive and resistant population, 
respectively). 
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Figure 19 : Cav inhibitors reduced the pH6-induced increase of Ca
2+ concentration in an amiloride-sensitive 
population of neurons 
Panel A shows an experiment in which the Cav inhibitors reduced the pH6-induced increase of Ca2+ concentration in an 
amiloride-sensitive neuron. Panel B shows an experiment in which the Cav inhibitors had no effect on the pH6-induced 
increase of Ca2+ concentration in an amiloride-resistant neuron. These effects are summarised in Panel C. Panel D shows 
that the Cav inhibitors were able to inhibit the increase of Ca2+ concentration in neurons after a KCl-mediated depolarization 
of the plasma membrane. **: p-value < 0.01 compared with “pH 6” value, ++: p-value < 0.01 compared with “KCl” value 
 
These experiments confirmed our hypothesis. They indicate that in the amiloride-sensitive population, 
ASIC channels mediate Ca
2+
 entry via the activation of the Cav channels and thus do not mediate 
themselves a sufficiently high Ca
2+
 entry. In the amiloride-insensitive population, the Cav inhibitors 
were uneffective. In these cells TRPV1 presumably allowed the entry of calcium.  
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3.2.5 Cav inhibitors do not affect PcTx1-sensitive Ca
2+
 entry 
In the experiments described in Figure 20, PcTx1 was used to identify neurons in wich the pH6-
induced Ca
2+
 entry was mainly due to the activity of homomeric ASIC1a. In the typical trace shown in 
panel A, the Cav inhibitors were uneffective to inhibit the pH6-induced increase of intracellular 
calcium concentration. The Cav inhibitors prevented partially the increase of intracellular Ca
2+
 
concentration after KCl-induced depolarisation. 
 
Figure 20 : Cav inhibitors had no effect on the pH6-induced increase of Ca
2+ concentration in an PcTx1-sensitive 
population of neurons  
Panel A shows that Cav inhibitors did not affect the pH6-induced increase in PcTx1 sensitive neurons. The data are 
summarized in panel B. n = 3 for each group. *: p-value < 0.05 compared with “pH 6” value, ++: p-value < 0.01 compared 
with “KCl” value 
In these experiments, only the PcTx1-sensitive neurons (i.e. >60% of the pH6-response inhibited by 
10 mM PcTx1) were used. PcTx1 concentration was 10 nM. The Cav inhibitor concentrations were as 
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before 10 µM for Nifedipine and Mibefradil and 300 nM for ω-conotoxin MVIIC. KCl was used at a 
concentration of 70 mM. Experiments in which the Cav inhibitors were ineffective to block the 
response to KCl (i.e. inhibition < 40 %) were not taken into account for the analysis. Unfortunately, in 
this set of experiments, the Cav were less effective to inhibit the KCl-induced increase of Ca
2+
 
concentration, that why we had to choose a lower threshold (40% instead of 60%). That’s why the 
results shown in this figure must be taken with caution. Panel B shows the quantification of the 
responses. As a population of PcTx1-sensitive neurons was selected, it is obvious that PcTx1 
significantly decreased the pH6-induced Ca
2+
 entry (paired t-test, p-value = 0.020). The Cav inhibitors 
were effective on the KCl responses (paired t-test p-value = 0.005), showing that even if the inhibition 
of the KCl-mediated depolarisation by Cav inhibitors was only partially effective, the inhibition was 
still statistically significant. The Cav inhibitors did not inhibit the pH6-induced increase of intracellular 
Ca
2+
 concentration (paired t-test, p-value = 0.324). We can conclude that in the population of neurons 
expressing only ASIC1a homomeric channels and no TRPV1 (i.e. PcTx1-sensitive neurons) activation 
of homomeric ASIC1a allowed the entry of calcium directly into the cells, as Cav inhibitors were 
unable to inhibit the pH6-activated increase of intracellular Ca
2+
 concentration.  
In Figure 19, we showed that in most of the amiloride-sensitive cells, the Cav inhibitors also inhibited 
a large part of the acid-induced increase of intracellular calcium concentration. On the contrary, we 
showed here that in a population of PcTx1-sensitive neurons, the Cav inhibitors did not inhibit the 
pH6-induced increase of intracellular Ca
2+
 concentration. As the PcTx1-sensitive neurons population 
is a subpopulation of the amiloride-sensitive neurons population, it is possible that none or 1 of the 5 
amiloride-sensitive cells averadged in Figure 19C were PcTx1-sensitive. A combined experiment with 
both amiloride and PcTx1 should be made to further understand the role of Cav in ASIC-mediated 
increase of intracellular Ca
2+
 concentration.   
To summarize, in this section we have shown that amiloride prevent Ca
2+
 entry through ASICs in a 
population of DRG neurons; that PcTx1 inhibits the activation of ASICs in another population of DRG 
neurons; that Cav inhibitors reduced the amplitude of ASIC-mediated Ca
2+
 increase in DRG neurons; 
and finally that Cav inhibitors did not affect pH6-mediated Ca
2+
 entry into PcTx1-sensitive population 
of DRG neurons. 
3.3 CGRP secretion assay on dissociated DRG neurons 
3.3.1 BCTC reduces CGRP secretion induced by an extracellular acidification in DRG 
neurons 
In order to measure directly the secretion of CGRP from DRG neurons, an in vitro assay was used to 
compare the secretion from neurons in a medium at physiological pH of 7.4 and from neurons exposed 
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to a more acidic pH. The duration of the secretion experiment was 15 min at 37°C. The amount of 
secreted CGRP is expressed as a percentage of the total CGRP content of the cells, named “relative 
CGRP secretion”. 
 
Figure 21 : Effect of extracellular acidification on CGRP secretion 
The duration of the secretion experiment was 15 min at 37°C. The relative secreted CGRP is expressed as a % of the secreted 
CGRP to the total CGRP content of the cells. Panel A shows the increase of CGRP secretion at pH6 and pH5. Panel B shows 
no significant effect of amiloride on acid-induced CGRP secretion. Pannel C shows r no significant effect of PcTx1 on CGRP 
secretion. Panel D shows that BCTC reduced the secretion at acidic pH back to pH7.4 secretion. n = 6-12 for panel A, n = 2-5 
for panel B, n = 3-5 for panel C, n = 5-9 for panel D. *: p-value < 0.05, **: p-value < 0.01 
Figure 21A shows that extracellular acidification to pH 6 or 5 both significantly increased the neuronal 
secretion of CGRP compared to the basal level at pH 7.4 (one-way ANOVA, followed by a Tukey 
post-hoc test, p-values = 0.012 and 0.045, respectively). An acidification to pH 6.5 did not increase the 
secretion, compared to the basal level at pH 7.4 (Tukey post-hoc test, p-value = 0.991).  
  
57 
 
In experiments presented on panels B and C, amiloride (500 µM) and PcTx1 (10 nm) were used as 
ASICs inhibitors to test for an involvement of ASICs in CGRP secretion. There were no significant 
differences between conditions with or without inhibitors (one-way ANOVA, followed by a Tukey 
post-hoc test). There was even a tendency for amiloride to increase the CGRP release, perhaps caused 
by non-specific effects of amiloride. In this context, amiloride is probably not an ideal inhibitor (see 
Discussion). 
In the experiments presented in panel D, the TRPV1 inhibitor BCTC (1 µM) was able to significantly 
reduce the CGRP secretion at pH 6 and 5 (one-way ANOVA, followed by a Tukey post-hoc test, p-
value = 0.007 and 0.03 respectively). These experiments show that TRPV1 is involved in the CGRP 
secretion triggered by an extracellular acidification. Even if these experiments were not able to 
demonstrate a role for ASICs in this secretion, we cannot totally exclude such a role (see Discussion). 
In Figure 22 effects of Cav and Nav inhibitors on CGRP secretion are shown. On panel A, Cav 
inhibitors (Nifedipine (10 µM), Mibefradil (10 µM) and ω-conotoxin MVIIC (300 nM)) had no 
significant effects on the secretion induced by an acidic extracellular solution (one-way ANOVA, 
followed by Tukey post-hoc tests). The inhibitors reduced however the secretion induced by 70 mM 
extracellular KCl (one-way ANOVA, followed by a Tukey post-hoc test, p-value = 0.009).At the same 
time this experiment indicates that the Cav are not involved in the extracellular acid-induced CGRP 
secretion.  
In experiments presented on panel B, the Nav inhibitors TTX (1 μM) and lidocaine (10 mM) were 
used. TTX or lidocaine separately had no signicative effect on the CGRP secretion (one-way ANOVA, 
followed by a Tukey post-hoc test, p-value = 0.41 and 0.83). If applied together, lidocaïne and TTX 
induced a small inhibition of secretion (Tukey post-hoc test, p-value = 0.007). These experiments do 
therefore indicate that Nav-mediated depolarization play a role in the secretion of CGRP. 
To conclude, the only effective and strong inhibitor in these experiments was BCTC. This indicates 
that TRPV1 is a major component of the detection of acidification that leads to CGRP secretion in 
these DRG neurons. Nav channel also play a role in these secretion. The exact mechanism which 
mediate the Nav-dependant CGRP secretion would necessitate more investigation to be elucidated. 
Likely, the Nav-induced depolarization potentiates the Cav activation. 
The Na/Ca exchanger (NCX) could also play a role in the secretion of CGRP. Na/Ca exchange is a 
mechanism that allows Ca
2+
 extrusion from the cell against its gradient without energy consumption. It 
is the entry of Na
+
 along its electrochemical gradient that provides the energy for Ca
2+
 extrusion. As 
NCX is electrogenic and voltage sensitive, it can reverse during cellular activation and contribute to 
Ca
2+
 entry into the cell (Blaustein & Lederer, 1999). As NCX are expressed in rat DRG neurons 
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(Verdru et al., 1997), we cannot exclude that NCX could play a role in Ca
2+
 entry after an acid-
induced depolarization, and therefore been implicated in an acid-induced CGRP secretion. Further 
experiments involving NCX inhibitors would be needed to assess the exact role of NCX in 
neuropeptides secretion. 
 
 
Figure 22 : Co-application of TTX and lidocaïne reduce acid-mediated CGRP secretion  
Panel A shows that Cav inhibitors had no significant effects on acid-induced CGRP secretion. Panel B shows that co-
application of Nav inhibitors TTX and lidocaïne reduced acid-mediated CGRP secretion. n = 2-7 for panel A, n= 2-8 for 
panel B *: p-value < 0.05, **: p-value < 0.01 
3.4 Behavioural experiments on ASIC1, ASIC2 and ASIC3 null mice. 
3.4.1 Mechanical allodynia-like behaviour induced by spared nerve injury (SNI) is not 
different from wild type in ASIC1a, -2 and 3 null mice 
We hypothesized that ASICs could have a role in neuropathic pain. This hypothesis was formulated 
based on the observation that in the SNI model of neuropathic pain performed on rats, the expression 
and function of different ASIC subunits in DRG neurons was changed (Poirot et al., 2006). To test this 
hypothesis, we applied the SNI model to three different mouse strains deficient of ASIC1a, -2 or -3. 
The mechanical allodynia induced by the nerve injury in the ipsilateral hindpaw was assessed with von 
Frey filaments. The ipsi- and the contralateral paw were stimulated 10 times each with filaments of 
increasing forces (see Methods for details). The number of response (i.e. the mouse withdraws it paw) 
out of 10 was recorded for each mouse, at different time points before and after the surgery. The 
selected time points in the following experiments are two baselines values and measurements taken at 
3, 9, 15 and 21 days after SNI surgery. As illustrated in Figure 23 for ASIC3 null mice and wild type 
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littermates, it has been previously shown that for wild type mice, the SNI model increases the 
allodynia over time until a plateau phase is reached (Bourquin et al., 2006). ASIC1a, -2 and -3 null 
mice were compared to wild type littermates. The experimenter did not know the genotype of the mice 
during the experiment. 
 
Figure 23 : Mechanical withdrawal threshold decreases significantly in ipsilateral paws after SNI for both ASIC3 
knockout mice and wild type mice 
The relative frequency of paw withdrawal at two different time points, one before and one after the 
surgery, is shown in Figure 24. For all mice, there was a significant difference between the ipsi- and 
contralateral paw starting from the third to the ninth post-operative day and persisting for the duration 
of the experiment (two-way analysis of variance (ANOVA), with time treated as a repeated measure), 
indicating that the mechanical allodynia was induced by the SNI model (data not shown).  
On panel A, results for ASIC1a null mice (n=10) and wild type littermates (n=10) are shown. There 
were no differences between the wild-type and the ASIC1a null mice at baseline 2 and at 21 days after 
SNI.  
On panel B, results for ASIC2 null mice (n = 19 for baseline 2, n = 9 for 21 day SNI) and wild type 
littermates (n = 18 for baseline 2, n = 8 for 21 day SNI) are shown. There were no differences between 
the wild-type and the ASIC2 null mice at baseline 2 and at 21 days after SNI.  
On panel C, results for ASIC3 null mice (n = 8) and wild type littermates (n = 7) are shown. There 
were no differences between the wild-type and the ASIC3 null mice at baseline 2. There was however 
a significant difference between the wild-type and the ASIC3 null mice at 21 day after SNI (p-value < 
0.0001). ASIC3 null mice were less sensitive than wild type littermates.  
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Panel D shows that mechanical withdrawal threshold decreases significantly in ipsilateral paws after 
SNI. 
 
 
Figure 24 : Relative frequencies of paw withdrawal are not significantly different in both wild type and null mice 
following SNI 
 Mechanical allodynia-like behaviour induced by spared nerve injury (SNI) is not different in ASIC1a (panel A), -2 (panel B) 
and 3 (panel C) null mice, compared to their respective wild type littermates. n = 10 mice per group for panel A, n = 8-19 
mice per group for panel B, n = 7-8 mice per group for panel C and D. 
To summarize, our study shows that there were no differences between the wild-type and the ASIC1, 
or ASIC2, null mice at baseline 2 and at 21 days after SNI. There was a significant difference between 
the wild-type and the ASIC3 null mice at 21 day SNI. ASIC3 null mice were less sensitive than wild 
type littermates. This shows that ASIC3 must be important in the development of allodynia after a 
nerve injury. 
3.4.2 ASIC2 null mice exhibit a reduced thermal allodynia-like behavior in the hot plate test 
We then decided to investigate the role of ASICs in thermal sensitivity, as it is almost unknown for 
ASIC1 and ASIC2. Figure 25 shows thermal allodynia assessed with tail flick and hot plate apparatus. 
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The tail flick test measures spinal nociception and it is based on the sensitivity of the mouse to 
temperature. Panels A, C and E show the results for the Tail Flick experiments. There were no 
significant differences between ASIC1a null mice (n = 10) and wild type littermates (n = 10), between 
ASIC2 null mice (n = 20) and wild type littermates (n = 20), nor between ASIC3 null mice (n = 10) 
and wild type littermates (n = 10) (t-test, p-value = 0.34, 0.16 and 0.37 respectively).  
The hot plate test is widely used to determine supraspinal nociception. Panels B, D and F show the 
results for the hot plate experiments at 49, 52, and 55°C for respectively ASIC1a, ASIC2 and ASIC3 
null mice. There was a significant difference at each temperature between ASIC1a and wild-type 
littermates (t-test, p-value = 0.041, 0.001, 0.003, respectively), and between ASIC2 null mice and 
wild-type littermates (t-test, p-value = 0.0002, 0.005, 0.0006, respectively). ASIC1a null mice had 
increased thermal allodynia behaviours with the hot plate compared to wild type littermates. On the 
contrary, ASIC2 null mice had reduced thermal allodynia behaviours with the hot plate compared to 
wild type littermates. There was no significant differences at each temperature between ASIC3 null 
mice and wild-type littermates (t-test, p-value = 0.26, 0.35, 0.72, respectively).  
To summarize, there was no difference between the different null mice and their littermates in the tail-
flick test. ASIC1a null mice were more sensitive and ASIC2 null mice were less sensitive to hot 
temperature in the hot plate test, compared to wild type littermates. ASIC3 null mice were no different 
from their wild type littermates in the Hot Plate test. These results indicate that ASIC1a and ASIC2 
must play a role in thermal sensation. As the effects were opposite in ASIC1a and in ASIC2 null mice, 
ASIC1a  and ASIC2 should be involved in different mechanisms. 
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Figure 25 : ASIC1a and ASIC2 null mice showed a significant difference in thermal with the hot plate test  
Panels A, C and E show no difference between ASIC1a, ASIC2 and respectively ASCI3 null mice and their wild type 
littermates with the tail flick test. Panel B shows increased thermal allodynia behaviour with the hot plate test between 
ASIC1a null mice and wild type littermates. Panel D shows reduced thermal allodynia behaviour with the hot plate test 
between ASIC2 null mice and wild type littermates. Panel F shows no difference for thermal allodynia behaviour with the hot 
plate test between ASIC3 null mice and wild type littermates. *: p-value < 0.05, **: p-value < 0.01 
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4. Discussion 
4.1 Expression of the different ASIC subunits and of neuropeptides 
4.1.1 Advantages and limitations of immunocytochemistry and in-situ hybridization    
Immunocytochemistry and in-situ hybridization were used to determine the distribution of the 
different ASIC subunits in two populations of DRG neurons, the petidergic and the non-peptidergic 
neurons. The main aim was to identify populations of DRG neurons which expressed different ASICs 
subunits, and to test for a possible correlation or co-expression between ASICs subunits and 
neuropeptides, and also between two different ASICs subunits. The main limitation of this technique is 
that it is only possible to measure the distribution of one ASIC subunit with one neuropeptide or one 
other ASIC subunit.  
The advantage of immunocytochemistry is that it detects the proteins. There are some limitations of 
this technique. The first limitation is that the available antibodies are not able to distinguish the splice 
variants (ASIC1a vs -1b, ASIC2a vs -2b). The second limitation is the quality of the antibodies. Most 
antibodies against ASICs are more or less efficient in recognising the proteins in a heterologous 
expression system, but most of them fail to specifically recognise ASICs in DRG neurons, except the 
two antibodies against ASIC1 and ASIC2, respectively, that were used in this study. Among all the 
antibodies we tested, we were only able to use one anti-ASIC1 and one anti-ASIC2 which were 
previously correctly tested, i.e. tested on tissues or neurons from knock-out mice.  
In order to detect the different splice variants ASIC1a, -1b, -2a, -2b and the ASIC3 isoform, we 
decided to switch to another method; the in-situ hybridization. The main advantage is, as previously 
mentioned, that all ASICs subunits can be distinguished. The main limitation of the technique is that it 
measures mRNA levels, thus it allows to detect cells expressing the mRNA of the different isoforms 
of ASICs, and not the proteins. Generally, the presence of a specific mRNA in a cell is a good 
indication that the corresponding protein is expressed, but regulation of the translation cannot be 
excluded.  
As already mentioned in the introduction, C-fiber nociceptors can be divided into two groups in which 
one class depends on NGF during postnatal development and contains neuropeptides, and the second 
class depends on GDNF during postnatal development and contains few neuropeptides but binds IB4 
(Basbaum et al., 2009). In our study, all ASICs were expressed in a higher fraction of the peptidergic 
population than the non-peptidergic population. 
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4.1.2 Comparison between the labelling of ASICs and the different types of ASIC currents 
Previously, an electrophysiological characterization of the different ASICs currents in dissociated rat 
DRG neurons was done by our group. The results showed that small-diameter DRG neurones 
expressed three different ASIC current types. Type 1 currents were mediated by ASIC1a 
homomultimers and characterized by steep pH dependence of current activation in the pH range 6.8–
6.0. Type 3 currents were activated in a similar pH range as type 1, while type 2 currents were 
activated at pH<6. PcTx1-sensitive ASIC1a current was predominantly found in IB4 negative, thus 
peptidergic neurons (Poirot et al., 2006). Staining done on dissociated DRG neurons confirmed that 
the ASIC1a subunit was predominantly expressed in peptidergic neurons.  
For ASIC1a, the electrophysiological experiments had identified a large population of DRG neurons 
which expressed only ASIC1a homomeric channels (type 1 current). In a different sub-population, 
ASIC1a likely participated in forming heteromeric channels with ASIC3 and probably other subunits 
giving rise to type 3 currents (Poirot et al., 2006). It should be noted that electrophysiological and 
biochemical experiments are not directly comparable. Our immunocytochemistry and in-situ 
hybridization showed that there are few neurons that express only ASIC1a. These results are in 
contradiction with the large population of expressing a type 1 current. Electrophysiological 
experiments give information on functional ASIC complexes present at the surface of the cell. 
Biochemical experiments give information on the whole cellular expression of ASICs protein or 
mRNA. Immunocytochemical and in situ hybridization experiments provide information about the 
expression of ASIC1a in a neuron, but not on the multimerization of the channel. Nevertheless, as we 
have shown that most ASIC subunits are expressed in the peptidergic neurons, it seems difficult to be 
compatible with the presence of pure homomeric ASIC1a current, as these neurons likely only express 
ASIC1a subunits at the cell surface. 
4.1.3 Comparison of the results of expression of ASICs, TRPV1, CGRP and SP with the 
literature 
In the following I compare our results with previous studies. One study involved an 
electrophysiological characterization of dissociated DRG neurons from adult rats. The DRG neurons 
were classified in nine different types according to their immunoreactivity to CGRP or SP and their 
patterns of capsaicin-, proton-, and ATP-activated currents. Out of these nine types, five were 
analysed. They formed distinct populations of capsaicin sensitive, ATP sensitive and proton sensitive 
cells with uniform current kinetics, pharmacology and histochemistry. Interestingly, a type of neuron 
expressed CGRP and TRPV1 and another one expressed fast desensitizing ASICs with a non-
desensitizing component. Two other populations did not express neuropeptides, but either ASICs or 
TRPV1 (Petruska et al., 2000). In a follow-up study, they discovered that the four other populations of 
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neurons formed distinct populations of medium sized capsaicin-sensitive and -insensitive cells that all 
expressed amiloride-sensitive, ASIC currents. The presence of ASIC currents was associated with the 
expression of neuropeptides SP and/or CGRP (Petruska et al., 2002). These results are consistent with 
our immunocytochemical and in-situ hybridization results that showed that ASIC1a, -1b, -3 and 
TRPV1 are preferentially expressed in neuropeptides neurons. It is difficult to compare our proportion 
of expression of the different ASICs and TRPV1 with neuropeptides with the proportion of the 
different cluster described in these studies, as it is not possible to calculate the proportions of neurons 
in their second study. The first study shows that ASICs and CGRP/SP are co-expressed in the cluster 7 
which represent 7 % of all neurons described in the study neurons of cluster 3 express ASICs but does 
not express neuropeptides in a proportion of 20 %. In the second study, the 4 remaining clusters 
express all neuropeptides and ASICs. As the neurons of these 4 clusters were the only ones to be 
measured in this study, it is impossible to calculate the proportion of each cluster. Nevertheless, the 
co-expression of ASICs and neuropeptides in 5 of the cluster likely shows a relatively high level of 
coexpression of ASICs with neuropeptides. These results were also confirmed in mice. It was found 
that IB4-negative neurons are the major class of unmyelinated neurons that responds to protons and 
capsaicin. IB4-negative unmyelinated neurons selectively expressed transient proton currents and 
these transient currents were reversibly blocked by amiloride, i.e. were mediated by ASICs. 
Furthermore, the authors think that a likely candidate for the sustained-only proton current was the 
capsaicin receptor TRPV1 (Dirajlal et al., 2003). A study demonstrated with a double 
immunofluorescence method that many ASIC3-immunoreactive neurons co-expressed CGRP in the 
jugular (about 80%) and petrosal ganglia (about 60%), confirming our results. It must be noted here 
that this result should be taken with caution, as the anti-ASIC3 antibody they were using was not 
working in our hands, and they did not carry out the necessary controls (Fukuda et al., 2006). In-situ 
hybridization on ASIC1a, -1b, -3 and TRPV1 has also been performed by a research group. They 
found that ASIC1a transcripts were expressed in 20-25% of the small diameter rat DRG neurons. 
ASIC1b was expressed in about 10% of neurons and ASIC3 in 30-35% of the neurons (Ugawa et al., 
2005). We also found that ASIC1b was less expressed than ASIC1a and ASIC3. The striking 
difference is that our results show more neurons expressing ASICs than in this paper (about 60 % for 
ASIC1a, 35-40% for ASIC1b and about 50 % for ASIC3). The most likely explanation is that they 
used radioactive probes which were less sensitive than our DIG-labelled probes detected with an anti-
DIG antibody coupled to a fluorophore which amplified the signal. They found that TRPV1 was 
expressed in 35-40% of neurons, which was not so different from what we found with 
immunocytochemistry (45-55%). 
For this part, we conclude that our results showing that ASIC1a, -1b, -3 and TRPV1 are preferentially 
expressed in the peptidergic population are confirmed in the literature by similar or completely 
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different methods (electrophysiology). We show here an interesting complete characterization of the 
expression of all ASIC subunits (except the non-conducting ASIC4) and TRPV1 and of their 
expression with neuropeptides CGRP and SP.  
4.2 Increase of intracellular calcium concentration via ASICs and TRPV1 
4.2.1 Effect of amiloride on the intracellular Ca2+ concentration of CHO cells expressing 
ASIC1a 
Amiloride induced a concentration dependent reduction of the increase of intracellular calcium 
concentration during an acidification. This demonstrates that ASIC1a homomeric channels are able to 
allow a significant increase of intracellular calcium concentration. This experiment was not able to 
show us the exact mechanism of increase of intracellular concentration. Obviously, calcium entered 
the cell via ASIC1a. It is not known if the totality of the calcium enters via ASIC1a, or if a small 
amount of calcium entering the cell via ASIC1a could trigger intracellular mechanisms that could 
release Ca
2+
 from intracellular stores.  
4.2.2 Effect of amiloride on the intracellular Ca2+ concentration of DRG neurons 
 Calcium imaging experiments were then performed on dissociated rat DRG neurons to understand 
how the intracellular calcium concentration of the neurons changes during an extracellular 
acidification. We showed that 500 μM amiloride prevented the increase of fluorescence at acidic pH 
by ≥ 70% in a population of cells that we named “Fully amiloride-sensitive”. As amiloride acts on 
ASICs and not TRPV1, this population of DRG neurons likely expressed mainly ASICs, and almost 
did not express TRPV1. The kinetics of the fluorescence were also compatible with ASICs, as the 
signal started to decrease still in presence of the acidification, reflecting the inactivation of ASICs. The 
kinetics would certainly be different if TRPV1 was involved, as TRPV1 does not inactivate. The 
calcium concentration remained high during the extracellular acidification and decreased only when 
the pH came back to pH 7.4. Likely this increase of calcium was mediated by a channel which does 
not inactivate, probably TRPV1 (see Figure 17). In the last population of cells which we named 
“Partially amiloride-sensitive” the amiloride was partially effective. This partial effectiveness showed 
that in these cells, as amiloride was only able to inhibit partially the increase of intracellular calcium 
concentration, ASICs were only partially responsible for this increase. 
4.2.3 Effect of PcTx1 on the intracellular Ca2+ concentration of DRG neurons 
In order to further analyse the “Amiloride-sensitive” population, in other words the population 
expressing ASIC channels responsible for the increase of intracellular calcium concentration, PcTx1, a 
toxin that inhibits homomeric ASIC1a channels, was used. It is useful here to remind that it has been 
extensively described in the literature that all ASIC channels are permeable for sodium but not for 
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divalent cations, except for ASIC1a homomeric channels which are permeable to sodium and calcium. 
The contribution of homomeric ASIC1a channels to the increase of intracellular Ca
2+
 concentration in 
neurons expressing ASICs but no TRPV1 was tested. PcTx1 abolished in a subpopulation the response 
to extracellular acidification. This indicates that in this subpopulation of neurons, ASIC1a homomeric 
channels were responsible for the increase of intracellular calcium concentration. There was also a 
neuronal population in which neither amiloride, nor PcTx1 affected the Ca
2+
 concentration at pH6, 
indicate that in these cells that ASICs were not involved in the extracellular acid-induced increase of 
intracellular calcium concentration. Considering that the “Partially amiloride-sensitive” population of 
neurons express both ASICs and TRPV1, 62% of the measured neurons expressed ASICs, 69% 
expressed TRPV1 and 20% only ASIC1a homomeric channels (31% of fully amiloride-sensitive 
neurons * 64% of the amiloride-sensitive neurons which were also PcTx1-sensitive).  The proportions 
for ASICs and TRPV1 are compatible with our results of the immunocytochemistry and in situ 
hybridization experiments. As previously mentioned, the immunocytochemistry and in situ 
hybridization experiments do not allow to know the oligomerization state of a channel, it is therefore 
difficult to discuss the ratio of ASIC1a homomeric channels. As PcTx1 is highly specific for 
homomeric ASIC1a, there is no doubt that the inhibition of increase of intracellular calcium 
concentration by this toxin reflects the inhibition of homomeric ASIC1a channels in our experiments. 
Nevertheless, we cannot exclude here that the entry of Na
+
 via ASIC1a could indirectly trigger the 
increase of intracellular calcium concentration by activating voltage-gated Ca
2+
 channels. 
4.2.4 Effect of Cavs on the intracellular Ca
2+
 concentration of DRG neurons 
As previously mentioned, calcium can enter the cell via the homomeric ASIC1a in the population of 
neurons which are sensitive to PcTx1. In the amiloride-sensitive, but PcTx1-insensitive DRG neuron 
population, calcium impermeant ASICs were involved in the increase of intracellular calcium 
concentration, thus the ASICs mediated indirectly the entry of calcium. Since we know that the entry 
of Na
+
 through ASICs can depolarize the plasma membrane, our hypothesis is that this depolarization 
can activate Cavs.  
In order to evaluate the role of Cav channels, three inhibitors (“the Cav inhibitors”) Nifedipine, 
Mibefradil and ω-conotoxin MVIIC were used together as pharmacological tools to inhibit a wide 
range of Cav. In most of the amiloride sensitive cells, the Cav inhibitors also blocked a large part of the 
acid-induced increase of intracellular calcium concentration. This result is consistent with the pathway 
depicted at the right of the Figure 26. The Cav inhibitors were uneffective to block the response to an 
extracellular acidification in a population of cells which were insensitive to amiloride. As previously 
mentionned, this population expresses TRPV1 as the main sensor of extracellular acidification. 
TRPV1 being highly permanent to calcium (Caterina et al., 1997; Mohapatra et al., 2003; Samways et 
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al., 2008), Cav are not necessary to allow an increase on the intracellular calcium concentration. It 
cannot be excluded that the Cav played a role in the increase of intracellular calcium concentration in 
those cells. 
 
 
Figure 26: Schematic drawing of a neuron expressing ion channels 
The drawing shows on the left homomeric ASIC1a channels which can be inhibited with PcTx1 and TRPV1 which can be 
inhibited by BCTC. On the right, it shows that an entry of Na+ trough amiloride-sensible ASICs can depolarize the cell. In 
our hypothesis, this depolarization could active Cavs and allow an entry of calcium, even in absence of homomeric ASIC1a 
or TRPV1. This depolarization is inhibited by Cavs antagonists Nifedipine, Mibefradil and ω-conotoxin MVIIC. 
PcTx1 was used to isolate the population of cells which expressed homomeric ASIC1a. In this 
population, the Cav inhibitors were ineffective in blocking the increase of the intracellular calcium 
concentration. The KCl-induced depolarization was partially blocked by Cav inhibitors in these 
experiments. In the PcTx1-sensitive neurons, Cav inhibitors failed to decrease the response at pH6. 
This set of experiment suggests that Ca
2+
 is able to enter the cells via homomeric ASIC1a, but it 
cannot be excluded that the Cav also played a role in this population of neurons, as the inhibition of 
Cav by their inhibitors was not completely effective.  
4.2.5 Comparison of our results on ASICs and TRPV1 function in DRG neurons with the 
literature 
Previously, calcium imaging has been performed on cultured DRG neurons from mice. A study has 
found that experiments performed with antagonists for P2X, ASIC, and TRPV1 receptors suggested 
that these three receptors act together to detect protons, ATP, and lactate when presented together in 
physiologically relevant concentrations (Light et al., 2008). Even if many groups show that the 
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homomeric ASIC1a are calcium permeant (Waldmann et al., 1997; Chu et al., 2002; Yermolaieva et 
al., 2004), a paper claims that ASIC1a channels conduct only negligible Ca
2+
 (Samways et al., 2009). 
There were unable to record any difference of fluorescence after activation of native and recombinant 
homomeric ASIC1a channels in calcium imaging experiments. As it is the only study that showed that 
homomeric ASIC1a were impermeant to Ca
2+
 and as I and others showed the contrary, I believe they 
are wrong. A study on rat DRG neurons demonstrated the expression of Ca
2+
-permeable ASICs, with 
simultaneous whole-cell recording and ratiometric imaging techniques, in peptidergic nociceptive 
neurons. The simultaneous recording of ASICs currents and increases of intracellular Ca
2+
 
concentration, which was prevented by the absence of extracellular Ca
2+
, show strong evidences for 
the presence of a Ca
2+
 permeable ASIC. Sensitivity to PcTx1 indicated the presence of Ca
2+
-permeable 
ASIC1a (Jiang et al., 2006). Another study also performing calcium imaging on mouse neurons 
showed that extracellular acidosis opened ASIC1a channels, which provided a pathway for Ca
2+
 entry 
and elevated intracellular Ca
2+
 concentration in wild type, but not ASIC1a knockout mouse 
hippocampal neurons. It shows that ASIC1a subunits are necessary for Ca
2+
 permeability of the 
ASICs, but it does not show that only homomeric ASIC1a are Ca
2+
 permeant. Acid application also 
raised Ca
2+
 concentration and evoked Ca
2+
 currents in heterologous cells expressing ASIC1a. They 
demonstrated that although ASIC2a is also expressed in central neurons, neither ASIC2a 
homomultimeric channels nor ASIC1a/2a heteromultimers showed H+-activated Ca
2+
 concentration 
elevation or Ca
2+
 currents, confirming the Ca
2+
 permeability of homomeric ASIC1a channels 
(Yermolaieva et al., 2004). A study on the mechanism by which toxic Ca
2+
 loading of cells occurs in 
the ischemic brain also shows an implication of ASIC1a homomeric channels in the increase of 
intracellular calcium concentration. They showed that acidosis activates Ca
2+
-permeable ASICs, 
inducing Ca
2+
-dependent, neuronal injury inhibited by ASIC blockers (Xiong et al., 2004).  
All these studies confirm what we observed with our own calcium imaging experiments. We showed 
that a population of neuron expressed ASICs which are important for the increase of intracellular 
calcium concentration. We also confirm, in a population of neurons, the importance of ASIC1a 
homomeric channels for the entry of calcium into the cell. The presence of a population of neurons 
insensitive to amiloride is compatible with the presence of the Ca
2+
 permeable TRPV1. 
4.3 Secretion of CGRP from DRG neurons 
4.3.1 Extracellular acidification induces CGRP secretion 
In order to measure directly the secretion of CGRP from DRG neurons, we have used an in vitro assay 
to compare the secretion from neurons in a medium at physiological pH of 7.4 and from neurons in a 
more acidic pH. Extracellular acidification to pH 6 and 5 both significantly increased the neuronal 
secretion of CGRP compared to the basal level at pH 7.4. An acidification at pH 6.5 did not increase 
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the secretion, compared to the basal level at pH 7.4. This shows that an extracellular acidification was 
able to trigger the secretion of CGRP. It is surprising that an acidification at pH6.5 had no effect on 
the secretion, as ASICs currents at pH6.5 are already almost maximal. A possible explanation could be 
that secretion of CGRP is not induced by ASICs, but rather by TRPV1, as TRPV1 is not activated at 
pH 6.5. 
4.3.2 Role of ASICs in acid-induced CGRP secretion 
Amiloride and PcTx1 were used as ASICs inhibitors to test if ASICs were involved in CGRP 
secretion. There were no significant differences in CGRP secretion between conditions with or without 
amiloride or PcTx1. PcTx1 has only an effect on the population of neurons which express mainly 
homomeric ASIC1a. All the other DRG neurons expressing other ASICs or TRPV1 are not affected by 
PcTx1. Therefore, it was not really a surprise that PcTx1 had no effect on the secretion of CGRP, as a 
large part of the small diameter neurons was not affected by the toxin (more than about 79%). More 
surprisingly, amiloride had no inhibitory effect on the secretion of CGRP by DRG neurons. Amiloride 
even had the tendency to increase the secretion of CGRP. The main difference between the secretion 
assay and the calcium imaging experiments was the duration of the exposition to amiloride, or to other 
inhibitory compounds. For the calcium imaging experiments, the cells were exposed to amiloride only 
a few seconds, while for the secretion assay experiments, the cells were exposed to amiloride for 15 
min. Although there is no doubt that amiloride act on ASICs during a brief exposition, as shown with 
calcium imaging experiments, it certainly also act on transporters. During a brief stimulation, the 
effect on the transporters has certainly no consequences. On the contrary, during a prolonged 
exposition, amiloride could inhibit transporters for several minutes and therefore the inhibition of 
these transporters could have effects on the neurons and their viability. It is known that amiloride act 
on many sodium channels/transporters, as for example the Na
+
/H
+
 exchanger (Masereel et al., 2003). It 
is possible that inhibiting such channels/transporters for min can stress the cells and allows unspecific 
release of CGRP. 
4.3.3 Role of Cavs in acid-induced CGRP secretion 
We also wanted to know if Cavs were necessary for the release of CGRP. Cav inhibitors had no 
significant effects on the secretion induced by an acidic extracellular solution. The inhibitors 
efficiently inhibited Cavs in control experiments, as they reduced the secretion induced by KCl-
induced depolarization. We can conclude that Cav were not involved in the extracellular acid-induced 
CGRP secretion. As our hypothesis was that Cav were activated by the entry of Na
+
 by ASICs, and that 
as mentioned before, we were not able to show an effect of ASICs on the secretion of CGRP, this 
result show that ASICs seems to play no or only a small role in the secretion of CGRP in this assay. 
Cav inhibitors were able to inhibit the increase of intracellular Ca
2+
 concentration in calcium imaging 
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experiments in a population of neurons sensitive to amiloride. On the contrary the Cav inhibitors were 
unable to inhibit this increase in a population which was resistant to amiloride. As the secretion is 
dependant of an increase of intracellular calcium concentration and as the secretion of CGRP was not 
inhibited by Cav inhibitors, we can conclude that the neurons secreting CGRP probably belong to the 
amiloride-resistant population.  
4.3.4 Role of TRPV1 in acid-induced CGRP secretion 
The TRPV1 blocker BCTC was able to significantly reduce the CGRP secretion at pH 6 and 5. This 
showed that TRPV1 activity was regulated for the CGRP secretion triggered by an extracellular 
acidification. Even if these experiments were not able to demonstrate a role for ASICs in this 
secretion, we cannot totally exclude such a role. As the sensibility of the EIA assay used to measure 
the amount of secreted CGRP was limited, neurons were incubated for 15 min. In physiological 
conditions, the nerve endings could be in presence of extracellular acidification for a shorter period. 
This could influence the mechanisms of CGRP secretion even if experiments in which the period of 
incubation was shorter (2 min) showed no difference of CGRP secretion compared to the situation 
after 15 min of incubation (data not shown), as 2 min might already be too long. One of the main 
differences between ASICs and TRPV1 are kinetics of inactivation. ASICs inactivate fast; most of the 
subunits, except those containing ASIC3 subunits, are completely inactivated after few seconds of 
exposition to an extracellular acidification. On the contrary, TRPV1 does not inactivate. It results, as 
we have shown in our group (Blanchard & Kellenberger, 2011), that even if during the first seconds of 
activation, ASICs transfer more charges than TRPV1, the situation is inverted in the case of a 
prolonged stimulation, as in our secretion experiments.  
4.3.5 Role of Navs in acid-induced CGRP secretion 
Navs inhibitors TTX and lidocaïne were applied with an acidic pH to investigate the potential roles of 
Navs in CGRP secretion. TTX or lidocaïne separately had no visible effect on the CGRP secretion. 
Together, lidocaïne and TTX had a significant effect. The role of Navs is not very clear here, as in this 
cellular system, as mentioned earlier, TRPV1 seems to be able to trigger the secretion of CGRP. It is 
possible that inhibiting Navs prevent a depolarization of the neuron which could be required for the 
CGRP secretion. It has already been shown that Nav1.8 channels play a role in SP secretion. The SP 
released from cultured DRG neurons of Nav1.8 knock-out mice exposed to either capsaicin or KCl was 
significantly lower than that from wild-type mice based on a radioimmunoassay. The SP level of L6 
DRG in Nav1.8 knock-out mice was also lower than that in wild-type mice. These results suggest that 
Nav1.8 is involved in the regulation of the release and synthesis of SP in the DRG neurons of wild-
type mice (Tang et al., 2008). Even if Nav1.8 is TTX-resistant, other Navs could also mediate 
neuropeptide secretion. A study investigated mechanisms that mediate CGRP release from the rat 
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colon in vitro. It is even surprising that lidocaine had either no significant or an inhibitory effect, when 
applied with TTX, on the CGRP secretion, as it has been reported that lidocaine can activate TRPV1 
and can induce a TRPV1-dependant CGRP secretion (Leffler et al., 2008). 
4.3.6 Comparison of our results on CGRP secretion from DRG neurons with the literature 
Capsaicin and low pH induced significant increases in CGRP release which was shown to be mediated 
by TRPV1 activation. The TRPV1 antagonists (2R)-4-(3-chloro-2pyridinyl)-2-methyl-N-[4-(tri-
fluoromethyl)phenyl]-1 piperazonecarboxamide (CTPC) and capsazepine inhibit this increase (Kaur et 
al., 2009). It has already been shown that TRPV1 is important for the release of CGRP. TRPV1 
knockout mice were employed to assess the TRPV1 contribution to tracheal responsiveness. Heat-
induced CGRP release depended entirely on extracellular calcium and partly on TRPV1 as knockout 
mice showed 60% less CGRP release at 45°C than wild types. Proton stimulation resulted in a 
maximum secretion at pH 5.7. Acid-induced secretions of CGRP were greatly reduced but not 
abolished in TRPV1 knockout mice. It was also found that amiloride at 30 μm, was ineffective in 
TRPV1 knockout mice and wild type mice (Kichko & Reeh, 2009). This is not a surprise as we neither 
found an inhibitory effect of amiloride at much higher concentrations (500 μm). Another study using a 
model of colonic inflammation showed that desensitization of colonic TRPV1 receptors prior to 
inflammation abolished SP increase in the urinary bladder but did not affect CGRP concentration in 
the urinary bladder. However desensitization caused a reduction in CGRP release from lumbosacral 
DRG neurons during acute phase of inflammation. This demonstrates that colonic inflammation 
triggers the release of pro-inflammatory neuropeptides SP and CGRP in the urinary bladder via 
activation of TRPV1 signaling mechanisms (Pan et al., 2010). The aim of a study was to investigate 
some receptors possibly involved in the proton-mediated CGRP release from the heart. Acidification 
at pH 5.7 and 5.2 caused significant increases in CGRP release in wild type mice but not in mice 
lacking the TRPV1 receptor. The same acid stimuli caused no significant differences in CGRP release 
between wild type and ASIC3 knockout. Capsaicin caused massive CGRP release in all mouse 
genotypes with the exception of TRPV1 knockout (Strecker et al., 2005). An acid-induced 
neuropeptide secretion can also in some situations not depend on TRPV1, or ASIC3 activation. In the 
stomach, Proton concentrations in the range of pH 2.5-0.5 stimulated the release of CGRP and 
substance P. Both TRPV1 and ASIC3 are expressed in the sensory neurons innervating the stomach 
walls. However, the proton-induced gastric CGRP release in mice lacking the TRPV1 or the ASIC3 
channels was the same as in corresponding wild-type mice (Auer et al., 2010). 
To conclude, the only effective inhibitors in the CGRP secretion experiments were BCTC and a 
combination of TTX and lidocaine. It seems that TRPV1 is a major component of the detection of 
acidification that leads to CGRP secretion in these DRG neurons. As described above, it has been 
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shown in many studies that TRPV1 plays a role in neuropeptide secretion. Some Navs (as Nav 1.8) 
could also play a role in the secretion of CGRP. We cannot exclude that ASICs play a role in the 
CGRP secretion, has we did not find an inhibitor of all ASICs which was more specific than 
amiloride. To our knowledge, no study showed a role for ASICs in neuropeptide secretion. 
4.4 Behavioural experiments with mice 
4.4.1 Mechanical allodynia-like behaviour induced by SNI 
Mechanical allodynia behaviour was induced by SNI in mice. For all mice, there was a significant 
difference of paw responses between the ipsilateral and the contralateral paw starting from third to the 
ninth post-operative day and persisting for the duration of the experiment, showing that the 
mechanical allodynia was induced by the SNI model. There were no differences between the wild-type 
and the ASIC1, or ASIC2, null mice at baseline 2 and at 21 days after SNI. There was a significant 
difference between the wild-type and the ASIC3 null mice at 21 day SNI. ASIC3 null mice were less 
sensitive than wild type littermates.  
Our hypothesis was that ASICs could have a role in neuropathic pain, as it has been previously 
observed in our group that in a model of neuropathic pain performed on rat, the relative expressions of 
the different ASIC subunits in rat DRG neurons were modified by the SNI model. In rat, type 1 and 
type 3 current densities were reduced in injured neurons after SNI (Poirot et al., 2006). As type 3 
current is formed of ASIC1a- and ASIC3- containing hetereromers, this current must be absent in 
ASIC3 knockout animals, which could reduce the development of allodynia, as a possible role for this 
modulation of ASICs expression after the SNI injury could be to develop allodynia.  
ASIC3 knockout mice were reported to have a small but significant increase of sensitivity compared to 
wild-type animals in a model of mechanical hyperalgesia induced with carrageenan. (Price et al., 
2001). The secondary mechanical hyperalgesia that develops after knee joint inflammation was 
abolished in ASIC3 null mice. (Ikeuchi et al., 2008). Similar results were obtained with carrageenan-
induced muscle inflammation. ASIC3 null mice develop primary muscle hyperalgesia but not 
secondary paw hyperalgesia (Walder et al., 2010). Recently, it has also been shown that reducing in-
vivo ASIC3 using artificial miRNAs inhibits both primary and secondary hyperalgesia after muscle 
inflammation in wild-type mice (Walder et al., 2011). Following hind paw inflammation with formalin 
injection, ASIC1 and ASIC2, but not ASIC3 null mice showed enhanced pain behaviour compared to 
wild type littermate, predominantly in the second phase of the test (Staniland & McMahon, 2008).  
It is necessary to remind here that our hypothesis was based on observations made on rat DRG 
neurons. In rat DRG neurons, ASIC1a/b and -3 are the predominant isoforms as ASIC2a/b are less 
expressed (Poirot et al., 2006). On the contrary, in mouse DRG neurons, ASIC2 are predominantly 
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expressed (Hughes et al., 2007). This could be an explanation why we did only see a small difference 
between ASIC3 knockout and wild type mice at 21 days after SNI. 
 
4.4.2 Thermal allodynia-like behaviour in the tail flick and the hot plate test 
Thermal sensitivity was assessed with tail flick and hot plate apparatus. For the tail flick experiments, 
there were no significant differences between either of the ASIC ko mice and their wild type 
littermates. For the hot plate experiments, at 49, 52, and 55°C, there were significant differences at 
each temperature between ASIC1a and ASIC2 null mice and their wild-type littermates. ASIC1a null 
mice had increased thermal allodynia behaviors with the hot plate compared to wild type littermates. 
On the contrary, ASIC2 null mice had reduced thermal allodynia behaviors with the hot plate 
compared to wild type littermates. There were no significant differences at each temperature between 
ASIC3 null mice and wild-type littermates.  
In a study, ASIC3 null mutant mice displayed more thermal allodynia-like behaviors, when stimuli of 
moderate to high intensity were used. This effect was observed in the hot-plate test (Chen et al., 2002). 
It has also been shown that ASIC3 null mice had a reduced latency to withdrawal to tail stimulation at 
52°C compared to wild type mice in the tail withdrawal test. ASIC1 and ASIC3 null mice show no 
difference of behaviour in Hargreaves’ and tail withdrawal tests. It was also shown that in tail 
immersion and hot plate tests, a large antinoceptive effect was observed following both intrathecal and 
intracerebroventricular injections of PcTx1 (Mazzuca et al., 2007), which is in in contradiction with 
our findings that ASIC1a null mice had increased thermal allodynia behaviors with the hot plate. A 
recent study has shown that the mean withdrawal latency to a slow radiant heat ramp was not different 
between ASIC1a, -2 and -3 triple knockout mice and wild type mice (Kang et al., 2012). Most of the 
studies using ASIC null mice animals were done on ASIC3 null mice. Even if all the thermal tests 
done in these studies were not directly comparable, increased, decreased or unchanged thermal 
allodynia were described. In our hot plate study, there was no difference of response between ASIC3 
null mice and wild type mice. This discrepancy in the results does not allow us to have a definitive 
conclusion on the role of ASICs in thermal sensation. 
The opposite reaction of ASIC1a and ASIC2 knockout mice is very surprising and would need further 
investigations to elucidate the mechanisms. A study on the effect of the temperature on the function of 
ASICs showed that the temperature has small effects on the acid-induced currents in rat DRG neurons.   
(Blanchard & Kellenberger, 2011). As ASICs are activated by an extracellular acidification, even if 
this activation is modulated by temperature, it is difficult to imagine a mechanism in which ASICs 
would be the temperature sensor. 
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4.5 Conclusion 
During my thesis, I have mainly worked on two projects. The aim of the project first project was to 
determine the role of ASICs in neuropeptide secretion. We hypothesized that some neurons expressing 
ASIC current types 1 may mediate neuropeptide secretion in DRG neurons. This hypothesis was 
formulated from the discovery that most of the neurons expressing ASIC current type 1 were 
expressing neuropeptides. The aim of the study was to determine whether the activation by 
extracellular acidification of ASICs in DRG neurons induces the release of neuropeptides, and to 
determine the implication of other relevant ion channels in this process. 
The second project was to determine the role of ASICs in neuropathic pain. We hypothesized that 
ASICs could have a role in neuropathic pain. This hypothesis was formulated based on the observation 
that in a model of neuropathic pain performed on rat, the relative expressions of the different ASICs 
subunits in DRG neurons were modified by the nerve injury. 
The experiments done during my thesis concerning my first project showed the distribution of the 
different ASIC subunits and of TRPV1 in the rat DRG neurons. We showed that different ASIC 
subunits and TRPV1 are co-expressed with neuropeptides CGRP and SP. Different populations of 
DRG neurons were described according their response to extracellular acidification and to various 
inhibitors. We have described a population of small diameter neurons which express ASICs. Some of 
the ASIC-expressing neurons form a sub-population of neurons expressing only ASIC1a homomeric 
channels. Another population insensitive to amiloride was found. This population likely expresses 
another acid-sensing channel, TRPV1. We showed that Cavs were involved in the ASIC-dependent 
increase of intracellular calcium concentration. We proposed a mechanism in which the activation of 
ASICs depolarizes the cell membrane and activates Cav channels to let enter Ca
2+
 in the neuron. 
Experiments on PcTx1-sensititive neurons expressing ASIC1a homomeric channels showed that Cav 
were not involved in this population of neurons and that Ca
2+
 likely enters the neurons via ASIC1a 
homomeric channels. We have shown, despite our first hypothesis that ASICs are able to trigger 
neuropeptides secretion that it was not the case in our conditions. ASICs don’t seem to play a role in 
CGRP secretion. We found that TRPV1 was able to trigger the secretion of neuropeptides. ASICs and 
especially ASIC1a are preferentially expressed in peptidergic small diameter neurons and play a role 
in the increase of intracellular calcium concentration.  
The second project was based on behavioral experiments performed with ASIC1a, -2 and -3 knockout 
mice. Mechanical allodynia behaviour was induced by SNI in mice. There were no differences 
between the wild-type and the ASIC1, or ASIC2, null mice at baseline 2 and at 21 days after SNI. 
There was a significant difference between the wild-type and the ASIC3 null mice at 21 day SNI. 
ASIC3 null mice were less sensitive than wild type littermates. Hot plate experiments showed that 
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ASIC1a null mice had increased thermal allodynia behaviours compared to wild type littermates and 
that on the contrary, ASIC2 null mice had reduced thermal allodynia behaviours compared to wild 
type littermates. 
4.6 Perspectives 
Concerning the neuropeptide secretion project, all the experiments were done in vitro. It would be 
interesting to perform in vivo experiments to further investigate the role of extracellular acidification 
and neuronal ASICs in neuropeptides secretion. We have already tried to performed experiments in 
which we measure the plasma extravasation in the skin as an indirect measure of the neuropeptides 
secretion. Briefly, anesthetized rat was intravenously injected with Evans blue dye which binds to the 
albumin of the blood. Acidic solutions were subcutaneously injected. A biopsy was taken at the site of 
injection and the blue dye that leaked into the skin was dissolved and measured. As this kind of 
experiment was difficult to make, an alternative would be to measure the increase of the blood flow 
with an Ultrasonic Doppler blood flow measuring apparatus.  
Knock-out animal would be very useful to be sure that ASICs play no role in CGRP secretion. But as 
mentioned before, mice are not the best model concerning ASIC channels as their distribution is 
completely different of the distribution in rat. We could use the dominant negative form of the ASIC3 
subunit generated by Mogil et al. (Mogil et al., 2005) and pack it into a virus. The virus would be 
intrathecally injected in DRG. Neurons of these DRG would be dissociated and used to make a 
secretion assay. 
For the behaviour experiments, it would be more useful to use rats instead of mice for the reason 
already described above. We could use the same virus as described above to test if a complete ASIC 
knockout rat would have different mechanical responses after the SNI model. If a difference was 
found, we could make knockdown rat for individual ASIC subunits to characterize which ASIC 
subunits would be implicated in mechanical allodynia after the SNI model. 
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5. Annexes 
5.1 Supplementary images of in-situ hybridization on DRG neurons 
   
 
Figure S1: Example of staining of ASIC1b with in-situ hybridization on DRG neurons  
ASIC1b antisense probe, shown in green, and anti CGRP antibody, shown in red are used. Scale bar: 100 µm. In the merged 
image, cells which are positive for NeuN, CGRP and ASIC1b appear yellow. 
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Figure S2: Example of staining of ASIC2a with in-situ hybridization on DRG neurons  
ASIC2a antisense probe, shown in green, and anti CGRP antibody, shown in red are used. Scale bar: 100 µm. In the merged 
image, cells which are positive for NeuN, CGRP and ASIC2a appear yellow. 
 
Figure S3: Example of staining of ASIC2b with in-situ hybridization on DRG neurons  
ASIC2b antisense probe, shown in green, and anti CGRP antibody, shown in red are used. Scale bar: 100 µm. In the merged 
image, cells which are positive for NeuN, CGRP and ASIC2b appear yellow. 
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Figure S4: Example of staining of ASIC3 with in-situ hybridization on DRG neurons  
ASIC3 antisense probe, shown in green, and anti CGRP antibody, shown in red are used. Scale bar: 100 µm. In the merged 
image, cells which are positive for NeuN, CGRP and ASIC3 appear yellow. 
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